|
OMIM |
Link |
Information gain |
01 |
|
RA
|
[NCBI]
|
0.00293943
|
|
|
SLE
|
[NCBI]
|
0.00143062
|
|
|
holoprosencephaly
|
[NCBI]
|
0.00122268
|
|
|
digeorge syndrome/velocardiofacial syndrome spectrum of malformation 2
|
[NCBI]
|
0.00111882
|
|
|
FSHMD1A
|
[NCBI]
|
0.00103137
|
|
|
DURS1
|
[NCBI]
|
0.000909679
|
|
|
ST3
|
[NCBI]
|
0.000760959
|
|
|
saccharopinuria
|
[NCBI]
|
0.00074539
|
|
|
DFNB33
|
[NCBI]
|
0.00074539
|
|
|
STUT2
|
[NCBI]
|
0.00074539
|
|
|
melanoma, cutaneous malignant, 4
|
[NCBI]
|
0.00074539
|
|
|
AS
|
[NCBI]
|
0.000694076
|
|
|
KSS
|
[NCBI]
|
0.000667338
|
|
|
van der woude syndrome modifier
|
[NCBI]
|
0.000646253
|
|
|
faciodigitogenital syndrome, recessive
|
[NCBI]
|
0.000646253
|
|
|
MAFD6
|
[NCBI]
|
0.00064262
|
|
|
brachydactyly-mental retardation syndrome
|
[NCBI]
|
0.000582212
|
|
|
BRCA3
|
[NCBI]
|
0.000582212
|
|
|
SHFM5
|
[NCBI]
|
0.000534839
|
|
|
DYT7
|
[NCBI]
|
0.000534839
|
|
|
diabetes mellitus, noninsulin-dependent, 3
|
[NCBI]
|
0.000497284
|
|
|
renal failure, progressive, with hypertension
|
[NCBI]
|
0.000466217
|
|
|
ocular motor apraxia
|
[NCBI]
|
0.000466217
|
|
|
robinow syndrome, autosomal dominant
|
[NCBI]
|
0.00043976
|
|
|
wernicke-korsakoff syndrome
|
[NCBI]
|
0.000416751
|
|
|
HYPX
|
[NCBI]
|
0.000396418
|
|
|
WM1
|
[NCBI]
|
0.000396418
|
|
|
short rib-polydactyly syndrome, type ii
|
[NCBI]
|
0.000361774
|
|
|
MYP2
|
[NCBI]
|
0.000333018
|
|
|
spermatogenic failure, nonobstructive, y-linked
|
[NCBI]
|
0.000332856
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive
|
[NCBI]
|
0.000323617
|
|
|
BRCA2
|
[NCBI]
|
0.00028074
|
|
|
MDD
|
[NCBI]
|
0.000279022
|
|
|
OCA2
|
[NCBI]
|
0.000255463
|
|
|
CRC
|
[NCBI]
|
0.000251173
|
|
|
VEGF
|
[NCBI]
|
0.000248428
|
|
|
PWS
|
[NCBI]
|
0.000240267
|
|
|
BMD
|
[NCBI]
|
0.000232618
|
|
|
MG
|
[NCBI]
|
0.00022704
|
|
|
CFTR
|
[NCBI]
|
0.000208728
|
|
|
AD
|
[NCBI]
|
0.000206249
|
|
|
KLK3
|
[NCBI]
|
0.00020574
|
|
|
NPY
|
[NCBI]
|
0.000202433
|
|
|
GJB2
|
[NCBI]
|
0.000201454
|
|
|
FA
|
[NCBI]
|
0.000195586
|
|
|
VHL
|
[NCBI]
|
0.000189116
|
|
|
APC
|
[NCBI]
|
0.000185313
|
|
|
NF1
|
[NCBI]
|
0.000184852
|
|
|
pearson marrow-pancreas syndrome
|
[NCBI]
|
0.000183642
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
0.000183324
|
|
|
kabuki syndrome
|
[NCBI]
|
0.000183324
|
|
|
TNF
|
[NCBI]
|
0.000181002
|
|
|
PTH
|
[NCBI]
|
0.000179956
|
|
|
pena-shokeir syndrome, type i
|
[NCBI]
|
0.000178497
|
|
|
BRCA1
|
[NCBI]
|
0.000175154
|
|
|
RP3
|
[NCBI]
|
0.000163629
|
|
|
wolfram syndrome, mitochondrial form
|
[NCBI]
|
0.000161724
|
|
|
PRL
|
[NCBI]
|
0.00015167
|
|
|
myoclonic dystonia
|
[NCBI]
|
0.000151123
|
|
|
DMD
|
[NCBI]
|
0.000150024
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
0.000146633
|
|
|
CCK
|
[NCBI]
|
0.000143637
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 2
|
[NCBI]
|
0.000143291
|
|
|
MNGIE
|
[NCBI]
|
0.000141808
|
|
|
EGF
|
[NCBI]
|
0.000140305
|
|
|
afibrinogenemia, congenital
|
[NCBI]
|
0.000135961
|
|
|
CMD1L
|
[NCBI]
|
0.000132916
|
|
|
DMD
|
[NCBI]
|
0.000132826
|
|
|
VIP
|
[NCBI]
|
0.000129756
|
|
|
NF2
|
[NCBI]
|
0.000127227
|
|
|
DYT1
|
[NCBI]
|
0.00012418
|
|
|
sotos syndrome
|
[NCBI]
|
0.00012418
|
|
|
SCS
|
[NCBI]
|
0.00012418
|
|
|
sertoli cell-only syndrome, y-linked
|
[NCBI]
|
0.000123717
|
|
|
DFNB1
|
[NCBI]
|
0.000121449
|
|
|
CJD
|
[NCBI]
|
0.000120731
|
|
|
CCR5
|
[NCBI]
|
0.000119315
|
|
|
papillorenal syndrome
|
[NCBI]
|
0.000118498
|
|
|
NPHP1
|
[NCBI]
|
0.00011808
|
|
|
CRH
|
[NCBI]
|
0.000117877
|
|
|
TH
|
[NCBI]
|
0.000117175
|
|
|
WBS
|
[NCBI]
|
0.000115476
|
|
|
NGFB
|
[NCBI]
|
0.000114395
|
|
|
RPGR
|
[NCBI]
|
0.000113758
|
|
|
C10ORF2
|
[NCBI]
|
0.000113748
|
|
|
SPD1
|
[NCBI]
|
0.000113743
|
|
|
NFNS
|
[NCBI]
|
0.000113743
|
|
|
cri-du-chat syndrome
|
[NCBI]
|
0.000113743
|
|
|
GFAP
|
[NCBI]
|
0.000111757
|
|
|
ACHE
|
[NCBI]
|
0.000110944
|
|
|
succinic semialdehyde dehydrogenase deficiency
|
[NCBI]
|
0.00010938
|
|
|
aging
|
[NCBI]
|
0.00010938
|
|
|
SGBS1
|
[NCBI]
|
0.000108225
|
|
|
ATP7A
|
[NCBI]
|
0.000101359
|
|
|
HFM
|
[NCBI]
|
0.000100858
|
|
|
PKD1
|
[NCBI]
|
9.82211e-05
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
9.72705e-05
|
|
|
AVP
|
[NCBI]
|
9.63689e-05
|
|
|
CD
|
[NCBI]
|
9.55264e-05
|
|
|
oguchi disease
|
[NCBI]
|
9.55092e-05
|
|
|
AIED
|
[NCBI]
|
9.48641e-05
|
|
|
WAS
|
[NCBI]
|
9.31059e-05
|
|
|
masa syndrome
|
[NCBI]
|
9.17994e-05
|
|
|
RSTS
|
[NCBI]
|
8.97214e-05
|
|
|
autism
|
[NCBI]
|
8.95057e-05
|
|
|
cutis laxa, x-linked
|
[NCBI]
|
8.89118e-05
|
|
|
pneumothorax, primary spontaneous
|
[NCBI]
|
8.84037e-05
|
|
|
chromosome 16p13.3 deletion syndrome
|
[NCBI]
|
8.84037e-05
|
|
|
giant platelet syndrome
|
[NCBI]
|
8.76548e-05
|
|
|
deafness, conductive, with stapes fixation
|
[NCBI]
|
8.61834e-05
|
|
|
hyaluronidase deficiency
|
[NCBI]
|
8.54353e-05
|
|
|
contiguous abcd1/dxs1375e deletion syndrome
|
[NCBI]
|
8.54353e-05
|
|
|
transaldolase deficiency
|
[NCBI]
|
8.54353e-05
|
|
|
polydactyly, imperforate anus, and vertebral anomalies
|
[NCBI]
|
8.54353e-05
|
|
|
CATCN3
|
[NCBI]
|
8.54353e-05
|
|
|
NPHS3
|
[NCBI]
|
8.54353e-05
|
|
|
hyperlipoproteinemia, type v
|
[NCBI]
|
8.54353e-05
|
|
|
cataract, cortical, juvenile-onset
|
[NCBI]
|
8.54353e-05
|
|
|
ROCA
|
[NCBI]
|
8.54353e-05
|
|
|
DFNB30
|
[NCBI]
|
8.54353e-05
|
|
|
radioulnar synostosis with amegakaryocytic thrombocytopenia
|
[NCBI]
|
8.54353e-05
|
|
|
hypotrichosis-lymphedema-telangiectasia syndrome
|
[NCBI]
|
8.54353e-05
|
|
|
RP30
|
[NCBI]
|
8.54353e-05
|
|
|
TSC2
|
[NCBI]
|
8.54114e-05
|
|
|
PSACH
|
[NCBI]
|
8.48689e-05
|
|
|
glycogen storage disease iii
|
[NCBI]
|
8.3599e-05
|
|
|
ALGS1
|
[NCBI]
|
8.3022e-05
|
|
|
SANDO
|
[NCBI]
|
8.24603e-05
|
|
|
GS1
|
[NCBI]
|
8.24603e-05
|
|
|
STAM2
|
[NCBI]
|
8.14193e-05
|
|
|
MPO
|
[NCBI]
|
8.10063e-05
|
|
|
PD
|
[NCBI]
|
7.97184e-05
|
|
|
OCA3
|
[NCBI]
|
7.73608e-05
|
|
|
CEACAM5
|
[NCBI]
|
7.72267e-05
|
|
|
DYT1
|
[NCBI]
|
7.63338e-05
|
|
|
SMS
|
[NCBI]
|
7.57523e-05
|
|
|
NSD1
|
[NCBI]
|
7.32485e-05
|
|
|
POF1
|
[NCBI]
|
7.24305e-05
|
|
|
PHS
|
[NCBI]
|
7.24305e-05
|
|
|
MTM1
|
[NCBI]
|
7.16032e-05
|
|
|
RCC1
|
[NCBI]
|
7.16032e-05
|
|
|
NPPA
|
[NCBI]
|
7.15045e-05
|
|
|
CHAT
|
[NCBI]
|
7.06072e-05
|
|
|
ACE
|
[NCBI]
|
6.97181e-05
|
|
|
OSMED
|
[NCBI]
|
6.89484e-05
|
|
|
LGMD2C
|
[NCBI]
|
6.68277e-05
|
|
|
CLN3
|
[NCBI]
|
6.66208e-05
|
|
|
SEDT
|
[NCBI]
|
6.5401e-05
|
|
|
PCNA
|
[NCBI]
|
6.52709e-05
|
|
|
apc gene
|
[NCBI]
|
6.44317e-05
|
|
|
mitochondrial complex iv deficiency
|
[NCBI]
|
6.34481e-05
|
|
|
SNRPN
|
[NCBI]
|
6.26266e-05
|
|
|
ATP7B
|
[NCBI]
|
6.26266e-05
|
|
|
ACCPN
|
[NCBI]
|
6.2189e-05
|
|
|
GAA
|
[NCBI]
|
6.17834e-05
|
|
|
LDLR
|
[NCBI]
|
6.17568e-05
|
|
|
MALL
|
[NCBI]
|
6.15241e-05
|
|
|
HGPS
|
[NCBI]
|
6.11199e-05
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
6.02159e-05
|
|
|
MTM1
|
[NCBI]
|
6.01126e-05
|
|
|
ATM
|
[NCBI]
|
5.98688e-05
|
|
|
LPG
|
[NCBI]
|
5.92582e-05
|
|
|
JLNS1
|
[NCBI]
|
5.92582e-05
|
|
|
ISS
|
[NCBI]
|
5.92582e-05
|
|
|
complement component 7 deficiency
|
[NCBI]
|
5.92582e-05
|
|
|
ND
|
[NCBI]
|
5.90571e-05
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
5.90571e-05
|
|
|
WFS1
|
[NCBI]
|
5.8826e-05
|
|
|
CLN3
|
[NCBI]
|
5.8826e-05
|
|
|
AT
|
[NCBI]
|
5.85178e-05
|
|
|
eiken skeletal dysplasia
|
[NCBI]
|
5.79449e-05
|
|
|
CDG1E
|
[NCBI]
|
5.79449e-05
|
|
|
aarskog syndrome
|
[NCBI]
|
5.79449e-05
|
|
|
JBTS4
|
[NCBI]
|
5.79449e-05
|
|
|
glycogen storage disease of heart, lethal congenital
|
[NCBI]
|
5.79449e-05
|
|
|
GS3
|
[NCBI]
|
5.79449e-05
|
|
|
nephropathy, chronic tubulointerstitial
|
[NCBI]
|
5.79449e-05
|
|
|
ALGS2
|
[NCBI]
|
5.79449e-05
|
|
|
MODY6
|
[NCBI]
|
5.79449e-05
|
|
|
heterotopia, periventricular, ehlers-danlos variant
|
[NCBI]
|
5.79449e-05
|
|
|
CREBBP
|
[NCBI]
|
5.71604e-05
|
|
|
RFXANK
|
[NCBI]
|
5.68637e-05
|
|
|
SLC25A4
|
[NCBI]
|
5.68528e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 1
|
[NCBI]
|
5.65666e-05
|
|
|
mowat-wilson syndrome
|
[NCBI]
|
5.65666e-05
|
|
|
CTNS
|
[NCBI]
|
5.60032e-05
|
|
|
CTNS
|
[NCBI]
|
5.57836e-05
|
|
|
WAS
|
[NCBI]
|
5.57638e-05
|
|
|
PARK2
|
[NCBI]
|
5.43185e-05
|
|
|
TUSC3
|
[NCBI]
|
5.42772e-05
|
|
|
IKZF1
|
[NCBI]
|
5.41936e-05
|
|
|
exostoses, multiple, type ii
|
[NCBI]
|
5.40811e-05
|
|
|
GCE
|
[NCBI]
|
5.40811e-05
|
|
|
pseudoxanthoma elasticum, forme fruste
|
[NCBI]
|
5.40811e-05
|
|
|
MBP
|
[NCBI]
|
5.40518e-05
|
|
|
MFS
|
[NCBI]
|
5.39412e-05
|
|
|
BDNF
|
[NCBI]
|
5.35173e-05
|
|
|
SMEI
|
[NCBI]
|
5.33615e-05
|
|
|
LPL
|
[NCBI]
|
5.25824e-05
|
|
|
refsum disease
|
[NCBI]
|
5.17748e-05
|
|
|
pituitary dwarfism iii
|
[NCBI]
|
5.17748e-05
|
|
|
IKBKG
|
[NCBI]
|
5.13429e-05
|
|
|
NBS1
|
[NCBI]
|
5.13429e-05
|
|
|
HAE
|
[NCBI]
|
5.08824e-05
|
|
|
SGCE
|
[NCBI]
|
5.00203e-05
|
|
|
CCD
|
[NCBI]
|
4.99001e-05
|
|
|
ABCC6
|
[NCBI]
|
4.97396e-05
|
|
|
PRPH2
|
[NCBI]
|
4.97396e-05
|
|
|
JPS
|
[NCBI]
|
4.96989e-05
|
|
|
MECP2
|
[NCBI]
|
4.96499e-05
|
|
|
glycogen storage disease iv
|
[NCBI]
|
4.9626e-05
|
|
|
EDMD
|
[NCBI]
|
4.85503e-05
|
|
|
MCPH6
|
[NCBI]
|
4.77454e-05
|
|
|
mullerian aplasia
|
[NCBI]
|
4.77454e-05
|
|
|
icos deficiency
|
[NCBI]
|
4.77454e-05
|
|
|
myotubular myopathy with abnormal genital development
|
[NCBI]
|
4.77454e-05
|
|
|
DFNA15
|
[NCBI]
|
4.77454e-05
|
|
|
chondrosarcoma
|
[NCBI]
|
4.77454e-05
|
|
|
otofaciocervical syndrome
|
[NCBI]
|
4.77454e-05
|
|
|
preaxial deficiency, postaxial polydactyly, and hypospadias
|
[NCBI]
|
4.77454e-05
|
|
|
MRX58
|
[NCBI]
|
4.77454e-05
|
|
|
ARVD11
|
[NCBI]
|
4.77454e-05
|
|
|
ehlers-danlos-like syndrome due to tenascin-x deficiency
|
[NCBI]
|
4.77454e-05
|
|
|
HJMD
|
[NCBI]
|
4.77454e-05
|
|
|
SMC
|
[NCBI]
|
4.77454e-05
|
|
|
ADCAD1
|
[NCBI]
|
4.77454e-05
|
|
|
deafness, sensorineural, and male infertility
|
[NCBI]
|
4.77454e-05
|
|
|
ESCS
|
[NCBI]
|
4.76165e-05
|
|
|
NPHP1
|
[NCBI]
|
4.76165e-05
|
|
|
SMN1
|
[NCBI]
|
4.72088e-05
|
|
|
UGT1A1
|
[NCBI]
|
4.69824e-05
|
|
|
RTT
|
[NCBI]
|
4.59724e-05
|
|
|
CDKN2A
|
[NCBI]
|
4.59677e-05
|
|
|
canavan disease
|
[NCBI]
|
4.57313e-05
|
|
|
PHYH
|
[NCBI]
|
4.55135e-05
|
|
|
HNF1B
|
[NCBI]
|
4.44799e-05
|
|
|
wilson disease
|
[NCBI]
|
4.44441e-05
|
|
|
POLG
|
[NCBI]
|
4.4185e-05
|
|
|
PAX3
|
[NCBI]
|
4.4107e-05
|
|
|
ABCD1
|
[NCBI]
|
4.4107e-05
|
|
|
GLC3A
|
[NCBI]
|
4.39576e-05
|
|
|
UCMD
|
[NCBI]
|
4.39576e-05
|
|
|
HOXA13
|
[NCBI]
|
4.3572e-05
|
|
|
P2RX5
|
[NCBI]
|
4.2979e-05
|
|
|
EXT1
|
[NCBI]
|
4.26157e-05
|
|
|
PMS2
|
[NCBI]
|
4.26157e-05
|
|
|
CCM
|
[NCBI]
|
4.23092e-05
|
|
|
AN2
|
[NCBI]
|
4.23092e-05
|
|
|
ehlers-danlos syndrome, type i
|
[NCBI]
|
4.22844e-05
|
|
|
FMR1
|
[NCBI]
|
4.19006e-05
|
|
|
POLB
|
[NCBI]
|
4.18344e-05
|
|
|
FLCN
|
[NCBI]
|
4.18344e-05
|
|
|
SCN8A
|
[NCBI]
|
4.18344e-05
|
|
|
BCNS
|
[NCBI]
|
4.17895e-05
|
|
|
WS1
|
[NCBI]
|
4.13653e-05
|
|
|
platelet disorder, familial, with associated myeloid malignancy
|
[NCBI]
|
4.12212e-05
|
|
|
CDG1D
|
[NCBI]
|
4.12212e-05
|
|
|
ARMD2
|
[NCBI]
|
4.12212e-05
|
|
|
ACG1B
|
[NCBI]
|
4.12212e-05
|
|
|
homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cble complementation type
|
[NCBI]
|
4.12212e-05
|
|
|
FHL4
|
[NCBI]
|
4.12212e-05
|
|
|
pelizaeus-merzbacher-like disease, autosomal recessive, 1
|
[NCBI]
|
4.12212e-05
|
|
|
antisense igf2r
|
[NCBI]
|
4.12212e-05
|
|
|
tietz syndrome
|
[NCBI]
|
4.12212e-05
|
|
|
xanthinuria, type i
|
[NCBI]
|
4.12212e-05
|
|
|
pancreatic agenesis, congenital
|
[NCBI]
|
4.12212e-05
|
|
|
ependymoma, familial
|
[NCBI]
|
4.12212e-05
|
|
|
SCA15
|
[NCBI]
|
4.12212e-05
|
|
|
atransferrinemia
|
[NCBI]
|
4.12212e-05
|
|
|
RD
|
[NCBI]
|
4.12212e-05
|
|
|
marshall-smith syndrome
|
[NCBI]
|
4.12212e-05
|
|
|
hyperoxaluria, primary, type ii
|
[NCBI]
|
4.12212e-05
|
|
|
anal atresia, hypospadias, and penoscrotal inversion
|
[NCBI]
|
4.12212e-05
|
|
|
fanconi anemia, complementation group j
|
[NCBI]
|
4.12212e-05
|
|
|
heterotaxy, visceral, 2, autosomal
|
[NCBI]
|
4.12212e-05
|
|
|
SCA27
|
[NCBI]
|
4.12212e-05
|
|
|
2-@methylbutyryl-coa dehydrogenase deficiency
|
[NCBI]
|
4.12212e-05
|
|
|
DFNB59
|
[NCBI]
|
4.12212e-05
|
|
|
hyperlysinemia
|
[NCBI]
|
4.12212e-05
|
|
|
cataract, autosomal dominant, multiple types 1
|
[NCBI]
|
4.12212e-05
|
|
|
lig4 syndrome
|
[NCBI]
|
4.12212e-05
|
|
|
ARF1
|
[NCBI]
|
4.07119e-05
|
|
|
CSNB1A
|
[NCBI]
|
4.07024e-05
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
4.07024e-05
|
|
|
USH2A
|
[NCBI]
|
4.07024e-05
|
|
|
OCRL
|
[NCBI]
|
4.0263e-05
|
|
|
PPARA
|
[NCBI]
|
4.01978e-05
|
|
|
myopathy, myofibrillar, desmin-related
|
[NCBI]
|
3.92034e-05
|
|
|
TCIRG1
|
[NCBI]
|
3.88293e-05
|
|
|
GTS
|
[NCBI]
|
3.87533e-05
|
|
|
CHM
|
[NCBI]
|
3.86774e-05
|
|
|
VWS
|
[NCBI]
|
3.86774e-05
|
|
|
GPC3
|
[NCBI]
|
3.85812e-05
|
|
|
TWIST1
|
[NCBI]
|
3.85812e-05
|
|
|
HPS
|
[NCBI]
|
3.81128e-05
|
|
|
gnas complex locus, antisense transcript
|
[NCBI]
|
3.79069e-05
|
|
|
C3ORF10
|
[NCBI]
|
3.79069e-05
|
|
|
CXORF6
|
[NCBI]
|
3.79069e-05
|
|
|
HPS3
|
[NCBI]
|
3.79069e-05
|
|
|
ERCC2
|
[NCBI]
|
3.78621e-05
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
3.78621e-05
|
|
|
SLC40A1
|
[NCBI]
|
3.78621e-05
|
|
|
SLS
|
[NCBI]
|
3.78262e-05
|
|
|
charge syndrome
|
[NCBI]
|
3.77804e-05
|
|
|
ehlers-danlos syndrome, type iv, autosomal dominant
|
[NCBI]
|
3.77804e-05
|
|
|
CACNA1F
|
[NCBI]
|
3.7512e-05
|
|
|
DGS
|
[NCBI]
|
3.74783e-05
|
|
|
oca2 gene
|
[NCBI]
|
3.7168e-05
|
|
|
IGF2
|
[NCBI]
|
3.67513e-05
|
|
|
macrocephaly/autism syndrome
|
[NCBI]
|
3.64426e-05
|
|
|
PCWH
|
[NCBI]
|
3.64426e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type ii
|
[NCBI]
|
3.64426e-05
|
|
|
niemann-pick disease, type c2
|
[NCBI]
|
3.64426e-05
|
|
|
peters-plus syndrome
|
[NCBI]
|
3.64426e-05
|
|
|
macrocephaly, benign familial
|
[NCBI]
|
3.64426e-05
|
|
|
mental retardation, x-linked, with cerebellar hypoplasia and distinctive facial appearance
|
[NCBI]
|
3.64426e-05
|
|
|
anemia, hypochromic microcytic
|
[NCBI]
|
3.64426e-05
|
|
|
RP7
|
[NCBI]
|
3.64426e-05
|
|
|
NAIC
|
[NCBI]
|
3.64426e-05
|
|
|
follicle-stimulating hormone deficiency, isolated
|
[NCBI]
|
3.64426e-05
|
|
|
witkop syndrome
|
[NCBI]
|
3.64426e-05
|
|
|
OPTB5
|
[NCBI]
|
3.64426e-05
|
|
|
PGL3
|
[NCBI]
|
3.64426e-05
|
|
|
keratosis palmoplantaris striata i
|
[NCBI]
|
3.64426e-05
|
|
|
RP15
|
[NCBI]
|
3.64426e-05
|
|
|
sea-blue histiocyte disease
|
[NCBI]
|
3.64426e-05
|
|
|
weyers acrofacial dysostosis
|
[NCBI]
|
3.64426e-05
|
|
|
mucopolysaccharidosis type iiid
|
[NCBI]
|
3.64426e-05
|
|
|
white sponge nevus of cannon
|
[NCBI]
|
3.64426e-05
|
|
|
DFNB6
|
[NCBI]
|
3.64426e-05
|
|
|
AH
|
[NCBI]
|
3.64426e-05
|
|
|
epidermolysis bullosa herpetiformis, dowling-meara type
|
[NCBI]
|
3.64426e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive
|
[NCBI]
|
3.64426e-05
|
|
|
AVSD2
|
[NCBI]
|
3.64426e-05
|
|
|
respiratory distress syndrome in premature infants
|
[NCBI]
|
3.64426e-05
|
|
|
CDHS
|
[NCBI]
|
3.64426e-05
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
3.64272e-05
|
|
|
lung cancer
|
[NCBI]
|
3.64272e-05
|
|
|
hepatocellular carcinoma
|
[NCBI]
|
3.64272e-05
|
|
|
LCA1
|
[NCBI]
|
3.64272e-05
|
|
|
AGL
|
[NCBI]
|
3.62941e-05
|
|
|
MYBPC3
|
[NCBI]
|
3.62941e-05
|
|
|
PMD
|
[NCBI]
|
3.61498e-05
|
|
|
AFP
|
[NCBI]
|
3.58424e-05
|
|
|
HOS
|
[NCBI]
|
3.53958e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
3.52342e-05
|
|
|
PIGA
|
[NCBI]
|
3.52201e-05
|
|
|
SLC26A2
|
[NCBI]
|
3.51622e-05
|
|
|
OPTB1
|
[NCBI]
|
3.51382e-05
|
|
|
TCOF
|
[NCBI]
|
3.46243e-05
|
|
|
AVPR2
|
[NCBI]
|
3.46114e-05
|
|
|
NYX
|
[NCBI]
|
3.44445e-05
|
|
|
hook, drosophila, homolog of, 1
|
[NCBI]
|
3.44445e-05
|
|
|
PPP2R1B
|
[NCBI]
|
3.44445e-05
|
|
|
GPC4
|
[NCBI]
|
3.44445e-05
|
|
|
TAF4
|
[NCBI]
|
3.44445e-05
|
|
|
APOE
|
[NCBI]
|
3.43554e-05
|
|
|
USH2A
|
[NCBI]
|
3.41054e-05
|
|
|
FANCA
|
[NCBI]
|
3.40211e-05
|
|
|
GNRH1
|
[NCBI]
|
3.38044e-05
|
|
|
SHOX
|
[NCBI]
|
3.34483e-05
|
|
|
JAG1
|
[NCBI]
|
3.34483e-05
|
|
|
CHEK2
|
[NCBI]
|
3.34483e-05
|
|
|
EXT2
|
[NCBI]
|
3.31149e-05
|
|
|
GLDC
|
[NCBI]
|
3.31149e-05
|
|
|
ALPS
|
[NCBI]
|
3.30869e-05
|
|
|
protocadherin-beta gene cluster
|
[NCBI]
|
3.26921e-05
|
|
|
MRT1
|
[NCBI]
|
3.26921e-05
|
|
|
methylmalonic aciduria, cbla type
|
[NCBI]
|
3.26921e-05
|
|
|
pyruvate dehydrogenase e3-binding protein deficiency
|
[NCBI]
|
3.26921e-05
|
|
|
cherubism
|
[NCBI]
|
3.26921e-05
|
|
|
charcot-marie-tooth disease and deafness
|
[NCBI]
|
3.26921e-05
|
|
|
patterned dystrophy of retinal pigment epithelium
|
[NCBI]
|
3.26921e-05
|
|
|
naxos disease
|
[NCBI]
|
3.26921e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-negative
|
[NCBI]
|
3.26921e-05
|
|
|
BDE
|
[NCBI]
|
3.26921e-05
|
|
|
nasopharyngeal carcinoma
|
[NCBI]
|
3.26921e-05
|
|
|
corticosterone methyloxidase type i deficiency
|
[NCBI]
|
3.26921e-05
|
|
|
elejalde disease
|
[NCBI]
|
3.26921e-05
|
|
|
azoospermia due to perturbations of meiosis
|
[NCBI]
|
3.26921e-05
|
|
|
DFNA11
|
[NCBI]
|
3.26921e-05
|
|
|
STK11
|
[NCBI]
|
3.23514e-05
|
|
|
PCCB
|
[NCBI]
|
3.21832e-05
|
|
|
EP300
|
[NCBI]
|
3.21832e-05
|
|
|
H19
|
[NCBI]
|
3.18257e-05
|
|
|
DIDO1
|
[NCBI]
|
3.18057e-05
|
|
|
PDHX
|
[NCBI]
|
3.18057e-05
|
|
|
PITPNM1
|
[NCBI]
|
3.18057e-05
|
|
|
EEF1A2
|
[NCBI]
|
3.18057e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
3.10893e-05
|
|
|
SOX9
|
[NCBI]
|
3.03311e-05
|
|
|
ENG
|
[NCBI]
|
3.03311e-05
|
|
|
FGA
|
[NCBI]
|
3.01032e-05
|
|
|
PAX6
|
[NCBI]
|
3.01032e-05
|
|
|
MLH1
|
[NCBI]
|
2.97689e-05
|
|
|
EBP
|
[NCBI]
|
2.96831e-05
|
|
|
PLCE1
|
[NCBI]
|
2.9674e-05
|
|
|
KRT6A
|
[NCBI]
|
2.9674e-05
|
|
|
ALDH5A1
|
[NCBI]
|
2.9674e-05
|
|
|
locus control region, beta
|
[NCBI]
|
2.9674e-05
|
|
|
AN1
|
[NCBI]
|
2.96209e-05
|
|
|
hand-foot-uterus syndrome
|
[NCBI]
|
2.96209e-05
|
|
|
PC1
|
[NCBI]
|
2.96209e-05
|
|
|
polymicrogyria, bilateral frontoparietal
|
[NCBI]
|
2.96209e-05
|
|
|
AOII
|
[NCBI]
|
2.96209e-05
|
|
|
cardiomyopathy, familial hypertrophic, with wolff-parkinson-white syndrome
|
[NCBI]
|
2.96209e-05
|
|
|
three m syndrome
|
[NCBI]
|
2.96209e-05
|
|
|
STL2
|
[NCBI]
|
2.96209e-05
|
|
|
NEM2
|
[NCBI]
|
2.96209e-05
|
|
|
GBS
|
[NCBI]
|
2.96209e-05
|
|
|
atrial septal defect with atrioventricular conduction defects
|
[NCBI]
|
2.96209e-05
|
|
|
methylcobalamin deficiency, cblg type
|
[NCBI]
|
2.96209e-05
|
|
|
winchester syndrome
|
[NCBI]
|
2.96209e-05
|
|
|
radioulnar synostosis
|
[NCBI]
|
2.96209e-05
|
|
|
CMAH
|
[NCBI]
|
2.96209e-05
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
2.95044e-05
|
|
|
DJS
|
[NCBI]
|
2.95044e-05
|
|
|
GDNF
|
[NCBI]
|
2.92266e-05
|
|
|
TTR
|
[NCBI]
|
2.92189e-05
|
|
|
glycogen storage disease ii
|
[NCBI]
|
2.90593e-05
|
|
|
L1CAM
|
[NCBI]
|
2.89477e-05
|
|
|
UBE3A
|
[NCBI]
|
2.89329e-05
|
|
|
CYP1B1
|
[NCBI]
|
2.89329e-05
|
|
|
PARK2
|
[NCBI]
|
2.85152e-05
|
|
|
EMD
|
[NCBI]
|
2.82181e-05
|
|
|
COL3A1
|
[NCBI]
|
2.80802e-05
|
|
|
USP9Y
|
[NCBI]
|
2.78875e-05
|
|
|
HAND2
|
[NCBI]
|
2.78875e-05
|
|
|
COL4A6
|
[NCBI]
|
2.78875e-05
|
|
|
KLF3
|
[NCBI]
|
2.78875e-05
|
|
|
EVC2
|
[NCBI]
|
2.78875e-05
|
|
|
ATP10A
|
[NCBI]
|
2.78875e-05
|
|
|
MTAP
|
[NCBI]
|
2.76616e-05
|
|
|
AP1GBP1
|
[NCBI]
|
2.71375e-05
|
|
|
MX2
|
[NCBI]
|
2.71375e-05
|
|
|
TRPC4AP
|
[NCBI]
|
2.71375e-05
|
|
|
BCL7C
|
[NCBI]
|
2.71375e-05
|
|
|
SSBP3
|
[NCBI]
|
2.71375e-05
|
|
|
AASS
|
[NCBI]
|
2.71375e-05
|
|
|
CREBL2
|
[NCBI]
|
2.71375e-05
|
|
|
BIN3
|
[NCBI]
|
2.71375e-05
|
|
|
STK38
|
[NCBI]
|
2.71375e-05
|
|
|
MIDN
|
[NCBI]
|
2.71375e-05
|
|
|
MACROD2
|
[NCBI]
|
2.71375e-05
|
|
|
SSBP4
|
[NCBI]
|
2.71375e-05
|
|
|
TUSC1
|
[NCBI]
|
2.71375e-05
|
|
|
RNUT1
|
[NCBI]
|
2.71375e-05
|
|
|
hook, drosophila, homolog of, 3
|
[NCBI]
|
2.71375e-05
|
|
|
KREMEN2
|
[NCBI]
|
2.71375e-05
|
|
|
TRAF3IP1
|
[NCBI]
|
2.71375e-05
|
|
|
STAG3
|
[NCBI]
|
2.71375e-05
|
|
|
CTAG1A
|
[NCBI]
|
2.71375e-05
|
|
|
FGFR2
|
[NCBI]
|
2.71217e-05
|
|
|
COMP
|
[NCBI]
|
2.70513e-05
|
|
|
hyperprolinemia, type i
|
[NCBI]
|
2.70326e-05
|
|
|
PHA2
|
[NCBI]
|
2.70326e-05
|
|
|
PARK7
|
[NCBI]
|
2.70326e-05
|
|
|
PGL4
|
[NCBI]
|
2.70326e-05
|
|
|
SC
|
[NCBI]
|
2.70326e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 3
|
[NCBI]
|
2.70326e-05
|
|
|
creatine deficiency syndrome, x-linked
|
[NCBI]
|
2.70326e-05
|
|
|
VHL
|
[NCBI]
|
2.66916e-05
|
|
|
CVID
|
[NCBI]
|
2.63695e-05
|
|
|
MLLT4
|
[NCBI]
|
2.63514e-05
|
|
|
SEMA5A
|
[NCBI]
|
2.63514e-05
|
|
|
G6PD
|
[NCBI]
|
2.61777e-05
|
|
|
OPA1
|
[NCBI]
|
2.57737e-05
|
|
|
MYCN
|
[NCBI]
|
2.5659e-05
|
|
|
PTCH1
|
[NCBI]
|
2.5659e-05
|
|
|
TG
|
[NCBI]
|
2.50458e-05
|
|
|
SHANK3
|
[NCBI]
|
2.50059e-05
|
|
|
GPSM1
|
[NCBI]
|
2.50059e-05
|
|
|
GBE1
|
[NCBI]
|
2.50059e-05
|
|
|
COMT
|
[NCBI]
|
2.49762e-05
|
|
|
LFS1
|
[NCBI]
|
2.4928e-05
|
|
|
currarino syndrome
|
[NCBI]
|
2.48053e-05
|
|
|
INAD1
|
[NCBI]
|
2.48053e-05
|
|
|
macular dystrophy, vitelliform, adult-onset
|
[NCBI]
|
2.48053e-05
|
|
|
por deficiency
|
[NCBI]
|
2.48053e-05
|
|
|
gitelman syndrome
|
[NCBI]
|
2.48053e-05
|
|
|
polydactyly, postaxial, type a1
|
[NCBI]
|
2.48053e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-negative
|
[NCBI]
|
2.48053e-05
|
|
|
GS2
|
[NCBI]
|
2.48053e-05
|
|
|
IHCM
|
[NCBI]
|
2.48053e-05
|
|
|
dyskeratosis congenita, autosomal dominant
|
[NCBI]
|
2.48053e-05
|
|
|
emanuel syndrome
|
[NCBI]
|
2.48053e-05
|
|
|
crigler-najjar syndrome, type ii
|
[NCBI]
|
2.48053e-05
|
|
|
AML
|
[NCBI]
|
2.48053e-05
|
|
|
HNF1A
|
[NCBI]
|
2.47869e-05
|
|
|
PJS
|
[NCBI]
|
2.47351e-05
|
|
|
ETV6
|
[NCBI]
|
2.45297e-05
|
|
|
SMA1
|
[NCBI]
|
2.43983e-05
|
|
|
ADCYAP1
|
[NCBI]
|
2.41689e-05
|
|
|
CD40LG
|
[NCBI]
|
2.39967e-05
|
|
|
DPYD
|
[NCBI]
|
2.39967e-05
|
|
|
KCNQ1
|
[NCBI]
|
2.3945e-05
|
|
|
COL5A2
|
[NCBI]
|
2.381e-05
|
|
|
SGCG
|
[NCBI]
|
2.381e-05
|
|
|
NR2E3
|
[NCBI]
|
2.381e-05
|
|
|
KLF1
|
[NCBI]
|
2.36139e-05
|
|
|
ALDH3A2
|
[NCBI]
|
2.34828e-05
|
|
|
SMAD4
|
[NCBI]
|
2.34828e-05
|
|
|
growth hormone insensitivity syndrome
|
[NCBI]
|
2.33279e-05
|
|
|
IL12B
|
[NCBI]
|
2.29871e-05
|
|
|
hyperostosis corticalis generalisata
|
[NCBI]
|
2.28582e-05
|
|
|
trifunctional protein deficiency
|
[NCBI]
|
2.28582e-05
|
|
|
hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
|
[NCBI]
|
2.28582e-05
|
|
|
liddle syndrome
|
[NCBI]
|
2.28582e-05
|
|
|
corneal dystrophy, gelatinous drop-like
|
[NCBI]
|
2.28582e-05
|
|
|
BRIC1
|
[NCBI]
|
2.28582e-05
|
|
|
DFNA2
|
[NCBI]
|
2.28582e-05
|
|
|
BRIP1
|
[NCBI]
|
2.27349e-05
|
|
|
SAG
|
[NCBI]
|
2.27349e-05
|
|
|
POU3F4
|
[NCBI]
|
2.27349e-05
|
|
|
MERTK
|
[NCBI]
|
2.27349e-05
|
|
|
ITPR1
|
[NCBI]
|
2.27349e-05
|
|
|
FOP
|
[NCBI]
|
2.25703e-05
|
|
|
TYR
|
[NCBI]
|
2.23565e-05
|
|
|
ELN
|
[NCBI]
|
2.23516e-05
|
|
|
PPOX
|
[NCBI]
|
2.20453e-05
|
|
|
pyruvate kinase deficiency of red cells
|
[NCBI]
|
2.18391e-05
|
|
|
MEF2C
|
[NCBI]
|
2.17594e-05
|
|
|
SGCD
|
[NCBI]
|
2.17594e-05
|
|
|
APOBEC1
|
[NCBI]
|
2.17594e-05
|
|
|
HMBS
|
[NCBI]
|
2.16078e-05
|
|
|
MTCO2
|
[NCBI]
|
2.15975e-05
|
|
|
OA1
|
[NCBI]
|
2.15975e-05
|
|
|
PMP22
|
[NCBI]
|
2.12254e-05
|
|
|
metachromatic leukodystrophy due to saposin b deficiency
|
[NCBI]
|
2.1135e-05
|
|
|
BDC
|
[NCBI]
|
2.1135e-05
|
|
|
feingold syndrome
|
[NCBI]
|
2.1135e-05
|
|
|
PFHB1A
|
[NCBI]
|
2.1135e-05
|
|
|
platelet glycoprotein iv deficiency
|
[NCBI]
|
2.1135e-05
|
|
|
HNPCC2
|
[NCBI]
|
2.1135e-05
|
|
|
corpus callosum, agenesis of
|
[NCBI]
|
2.1135e-05
|
|
|
BOS1
|
[NCBI]
|
2.1135e-05
|
|
|
wagr syndrome
|
[NCBI]
|
2.1135e-05
|
|
|
MCOPS3
|
[NCBI]
|
2.1135e-05
|
|
|
kniest dysplasia
|
[NCBI]
|
2.1135e-05
|
|
|
brody myopathy
|
[NCBI]
|
2.1135e-05
|
|
|
marshall syndrome
|
[NCBI]
|
2.1135e-05
|
|
|
DRRS
|
[NCBI]
|
2.1135e-05
|
|
|
RMS2
|
[NCBI]
|
2.1135e-05
|
|
|
gracile syndrome
|
[NCBI]
|
2.1135e-05
|
|
|
CMT2A2
|
[NCBI]
|
2.1135e-05
|
|
|
XPV
|
[NCBI]
|
2.1135e-05
|
|
|
ichthyosis vulgaris
|
[NCBI]
|
2.1135e-05
|
|
|
BWS
|
[NCBI]
|
2.11275e-05
|
|
|
TRAPPC2
|
[NCBI]
|
2.08674e-05
|
|
|
NCF2
|
[NCBI]
|
2.08674e-05
|
|
|
UBB
|
[NCBI]
|
2.08674e-05
|
|
|
ASPA
|
[NCBI]
|
2.07435e-05
|
|
|
ALD
|
[NCBI]
|
2.06296e-05
|
|
|
ACP5
|
[NCBI]
|
2.05499e-05
|
|
|
TFPI
|
[NCBI]
|
2.03919e-05
|
|
|
FBN1
|
[NCBI]
|
2.02109e-05
|
|
|
JUP
|
[NCBI]
|
2.00464e-05
|
|
|
POLH
|
[NCBI]
|
2.00464e-05
|
|
|
NEFH
|
[NCBI]
|
2.00464e-05
|
|
|
MRXS13
|
[NCBI]
|
1.95948e-05
|
|
|
plasminogen deficiency, type i
|
[NCBI]
|
1.95948e-05
|
|
|
carbamoyl phosphate synthetase i deficiency, hyperammonemia due to
|
[NCBI]
|
1.95948e-05
|
|
|
von willebrand disease, recessive form
|
[NCBI]
|
1.95948e-05
|
|
|
encephalopathy, neonatal severe, due to mecp2 mutations
|
[NCBI]
|
1.95948e-05
|
|
|
SMDP1
|
[NCBI]
|
1.95948e-05
|
|
|
gaucher disease, type ii
|
[NCBI]
|
1.95948e-05
|
|
|
acheiropody
|
[NCBI]
|
1.95948e-05
|
|
|
renal cysts and diabetes syndrome
|
[NCBI]
|
1.95948e-05
|
|
|
PMDS
|
[NCBI]
|
1.95948e-05
|
|
|
CLN5
|
[NCBI]
|
1.95948e-05
|
|
|
medulloblastoma
|
[NCBI]
|
1.95948e-05
|
|
|
XPF
|
[NCBI]
|
1.95948e-05
|
|
|
DES
|
[NCBI]
|
1.95565e-05
|
|
|
MYH11
|
[NCBI]
|
1.95565e-05
|
|
|
KCNQ2
|
[NCBI]
|
1.92866e-05
|
|
|
INVS
|
[NCBI]
|
1.92866e-05
|
|
|
SGSH
|
[NCBI]
|
1.92866e-05
|
|
|
SLC26A3
|
[NCBI]
|
1.92866e-05
|
|
|
PDHA1
|
[NCBI]
|
1.91834e-05
|
|
|
LIFR
|
[NCBI]
|
1.91834e-05
|
|
|
SHBG
|
[NCBI]
|
1.906e-05
|
|
|
DNAJC4
|
[NCBI]
|
1.89523e-05
|
|
|
BCL7A
|
[NCBI]
|
1.89523e-05
|
|
|
myoinositol 1-phosphate synthase a1
|
[NCBI]
|
1.89523e-05
|
|
|
MYRIP
|
[NCBI]
|
1.89523e-05
|
|
|
DHRS4
|
[NCBI]
|
1.89523e-05
|
|
|
CARKL
|
[NCBI]
|
1.89523e-05
|
|
|
hook, drosophila, homolog of, 2
|
[NCBI]
|
1.89523e-05
|
|
|
GLIS1
|
[NCBI]
|
1.89523e-05
|
|
|
GCN1L1
|
[NCBI]
|
1.89523e-05
|
|
|
PLAGL2
|
[NCBI]
|
1.89523e-05
|
|
|
TMIE
|
[NCBI]
|
1.89523e-05
|
|
|
MYO3A
|
[NCBI]
|
1.89523e-05
|
|
|
RYBP
|
[NCBI]
|
1.89523e-05
|
|
|
NOLC1
|
[NCBI]
|
1.89523e-05
|
|
|
TCF19
|
[NCBI]
|
1.89523e-05
|
|
|
BCL7B
|
[NCBI]
|
1.89523e-05
|
|
|
EP400
|
[NCBI]
|
1.89523e-05
|
|
|
FCGR3B
|
[NCBI]
|
1.89523e-05
|
|
|
FAM57A
|
[NCBI]
|
1.89523e-05
|
|
|
PCBP3
|
[NCBI]
|
1.89523e-05
|
|
|
CNKSR1
|
[NCBI]
|
1.89523e-05
|
|
|
FSD1
|
[NCBI]
|
1.89523e-05
|
|
|
KREMEN1
|
[NCBI]
|
1.89523e-05
|
|
|
STARD3NL
|
[NCBI]
|
1.89523e-05
|
|
|
CHAF1A
|
[NCBI]
|
1.89523e-05
|
|
|
CBX4
|
[NCBI]
|
1.89523e-05
|
|
|
B3GALTL
|
[NCBI]
|
1.89523e-05
|
|
|
TWISTNB
|
[NCBI]
|
1.89523e-05
|
|
|
SIN3B
|
[NCBI]
|
1.89523e-05
|
|
|
KIAA0391
|
[NCBI]
|
1.89523e-05
|
|
|
EFS
|
[NCBI]
|
1.89523e-05
|
|
|
TOR2A
|
[NCBI]
|
1.89523e-05
|
|
|
DYRK4
|
[NCBI]
|
1.89523e-05
|
|
|
FZD9
|
[NCBI]
|
1.89523e-05
|
|
|
ROPN1
|
[NCBI]
|
1.89523e-05
|
|
|
TTC7A
|
[NCBI]
|
1.89523e-05
|
|
|
MMAA
|
[NCBI]
|
1.89523e-05
|
|
|
B3GAT3
|
[NCBI]
|
1.89523e-05
|
|
|
ANP32D
|
[NCBI]
|
1.89523e-05
|
|
|
ZFP161
|
[NCBI]
|
1.89523e-05
|
|
|
RPS6KA6
|
[NCBI]
|
1.89523e-05
|
|
|
PIK3C2G
|
[NCBI]
|
1.89523e-05
|
|
|
hepatocellular carcinoma-associated antigen 112
|
[NCBI]
|
1.89523e-05
|
|
|
FMNL
|
[NCBI]
|
1.89523e-05
|
|
|
proapoptotic caspase adaptor protein
|
[NCBI]
|
1.89523e-05
|
|
|
EXOSC1
|
[NCBI]
|
1.89523e-05
|
|
|
TOMM22
|
[NCBI]
|
1.89523e-05
|
|
|
BRCC3
|
[NCBI]
|
1.89523e-05
|
|
|
DVL1L1
|
[NCBI]
|
1.89523e-05
|
|
|
NKX6-2
|
[NCBI]
|
1.89523e-05
|
|
|
RAPGEF4
|
[NCBI]
|
1.89523e-05
|
|
|
dual adaptor of phosphotyrosine and 3-phosphoinositides 1
|
[NCBI]
|
1.89523e-05
|
|
|
TSPYL1
|
[NCBI]
|
1.89523e-05
|
|
|
PPP1R8
|
[NCBI]
|
1.89523e-05
|
|
|
TMSB4Y
|
[NCBI]
|
1.89523e-05
|
|
|
SSBP2
|
[NCBI]
|
1.89523e-05
|
|
|
SEC15L1
|
[NCBI]
|
1.89523e-05
|
|
|
TOR1B
|
[NCBI]
|
1.89523e-05
|
|
|
GMIP
|
[NCBI]
|
1.89523e-05
|
|
|
LHX3
|
[NCBI]
|
1.858e-05
|
|
|
UTRN
|
[NCBI]
|
1.858e-05
|
|
|
NCF1
|
[NCBI]
|
1.858e-05
|
|
|
LWD
|
[NCBI]
|
1.85359e-05
|
|
|
GHR
|
[NCBI]
|
1.84391e-05
|
|
|
IDUA
|
[NCBI]
|
1.83452e-05
|
|
|
ARH
|
[NCBI]
|
1.82069e-05
|
|
|
adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency
|
[NCBI]
|
1.82069e-05
|
|
|
bartter syndrome, antenatal, type 2
|
[NCBI]
|
1.82069e-05
|
|
|
CMD3B
|
[NCBI]
|
1.82069e-05
|
|
|
MCDS
|
[NCBI]
|
1.82069e-05
|
|
|
acyl-coa dehydrogenase, short-chain, deficiency of
|
[NCBI]
|
1.82069e-05
|
|
|
chromosome 22q13.3 deletion syndrome
|
[NCBI]
|
1.82069e-05
|
|
|
DSMA1
|
[NCBI]
|
1.82069e-05
|
|
|
indifference to pain, congenital, autosomal recessive
|
[NCBI]
|
1.82069e-05
|
|
|
EDM1
|
[NCBI]
|
1.82069e-05
|
|
|
amelogenesis imperfecta, hypoplastic/hypomaturation, x-linked 1
|
[NCBI]
|
1.82069e-05
|
|
|
d-bifunctional protein deficiency
|
[NCBI]
|
1.82069e-05
|
|
|
ARNT
|
[NCBI]
|
1.8112e-05
|
|
|
IL2
|
[NCBI]
|
1.79896e-05
|
|
|
NPS
|
[NCBI]
|
1.79386e-05
|
|
|
MEF2A
|
[NCBI]
|
1.79203e-05
|
|
|
CRYBA1
|
[NCBI]
|
1.79203e-05
|
|
|
COL11A1
|
[NCBI]
|
1.79203e-05
|
|
|
C7
|
[NCBI]
|
1.79203e-05
|
|
|
PAX1
|
[NCBI]
|
1.79203e-05
|
|
|
TP53
|
[NCBI]
|
1.77748e-05
|
|
|
LNS
|
[NCBI]
|
1.73602e-05
|
|
|
PFKM
|
[NCBI]
|
1.73018e-05
|
|
|
SURF1
|
[NCBI]
|
1.73018e-05
|
|
|
TSIX
|
[NCBI]
|
1.73018e-05
|
|
|
NRIP1
|
[NCBI]
|
1.73018e-05
|
|
|
LQT3
|
[NCBI]
|
1.69478e-05
|
|
|
GCCD1
|
[NCBI]
|
1.69478e-05
|
|
|
CORDX1
|
[NCBI]
|
1.69478e-05
|
|
|
protocadherin-alpha gene cluster
|
[NCBI]
|
1.69478e-05
|
|
|
mitochondrial dna depletion syndrome, hepatocerebral form
|
[NCBI]
|
1.69478e-05
|
|
|
ARVD1
|
[NCBI]
|
1.69478e-05
|
|
|
diabetes insipidus, nephrogenic, autosomal
|
[NCBI]
|
1.69478e-05
|
|
|
PPS
|
[NCBI]
|
1.69478e-05
|
|
|
trichodentoosseous syndrome
|
[NCBI]
|
1.69478e-05
|
|
|
STGD3
|
[NCBI]
|
1.69478e-05
|
|
|
methionine adenosyltransferase deficiency
|
[NCBI]
|
1.69478e-05
|
|
|
alpers diffuse degeneration of cerebral gray matter with hepatic cirrhosis
|
[NCBI]
|
1.69478e-05
|
|
|
XDH
|
[NCBI]
|
1.69397e-05
|
|
|
COL7A1
|
[NCBI]
|
1.68374e-05
|
|
|
HNPP
|
[NCBI]
|
1.67999e-05
|
|
|
NF2
|
[NCBI]
|
1.67999e-05
|
|
|
FOXL2
|
[NCBI]
|
1.67203e-05
|
|
|
PCDH15
|
[NCBI]
|
1.67203e-05
|
|
|
FRAXE
|
[NCBI]
|
1.67203e-05
|
|
|
LMX1B
|
[NCBI]
|
1.67203e-05
|
|
|
TERF2
|
[NCBI]
|
1.67203e-05
|
|
|
MSTN
|
[NCBI]
|
1.65355e-05
|
|
|
WHS
|
[NCBI]
|
1.63306e-05
|
|
|
CD
|
[NCBI]
|
1.63306e-05
|
|
|
maple syrup urine disease
|
[NCBI]
|
1.62571e-05
|
|
|
EPO
|
[NCBI]
|
1.6182e-05
|
|
|
RAG2
|
[NCBI]
|
1.61719e-05
|
|
|
NR4A3
|
[NCBI]
|
1.61719e-05
|
|
|
AMELX
|
[NCBI]
|
1.61719e-05
|
|
|
DBT
|
[NCBI]
|
1.61719e-05
|
|
|
BTK
|
[NCBI]
|
1.61659e-05
|
|
|
PXE
|
[NCBI]
|
1.61469e-05
|
|
|
SH2D1A
|
[NCBI]
|
1.59532e-05
|
|
|
CTGF
|
[NCBI]
|
1.59349e-05
|
|
|
PSAT1
|
[NCBI]
|
1.59018e-05
|
|
|
EXOSC5
|
[NCBI]
|
1.59018e-05
|
|
|
CADPS2
|
[NCBI]
|
1.59018e-05
|
|
|
ERBB2IP
|
[NCBI]
|
1.59018e-05
|
|
|
RIN1
|
[NCBI]
|
1.59018e-05
|
|
|
PHF20
|
[NCBI]
|
1.59018e-05
|
|
|
ANXA11
|
[NCBI]
|
1.59018e-05
|
|
|
prader-willi/angelman region 1
|
[NCBI]
|
1.59018e-05
|
|
|
PORCN
|
[NCBI]
|
1.59018e-05
|
|
|
TCBA1
|
[NCBI]
|
1.59018e-05
|
|
|
TKTL1
|
[NCBI]
|
1.59018e-05
|
|
|
NDUFA8
|
[NCBI]
|
1.59018e-05
|
|
|
ARHGAP4
|
[NCBI]
|
1.59018e-05
|
|
|
TRAM2
|
[NCBI]
|
1.59018e-05
|
|
|
BNIPL
|
[NCBI]
|
1.59018e-05
|
|
|
NDUFS7
|
[NCBI]
|
1.59018e-05
|
|
|
TTF1
|
[NCBI]
|
1.59018e-05
|
|
|
LETM1
|
[NCBI]
|
1.59018e-05
|
|
|
ACAD8
|
[NCBI]
|
1.59018e-05
|
|
|
VCPIP1
|
[NCBI]
|
1.59018e-05
|
|
|
GTF2F2
|
[NCBI]
|
1.59018e-05
|
|
|
CSNK1A1
|
[NCBI]
|
1.59018e-05
|
|
|
HOXA11
|
[NCBI]
|
1.59018e-05
|
|
|
ANP32C
|
[NCBI]
|
1.59018e-05
|
|
|
PRIM2A
|
[NCBI]
|
1.59018e-05
|
|
|
c-maf-inducing protein
|
[NCBI]
|
1.59018e-05
|
|
|
CTH
|
[NCBI]
|
1.59018e-05
|
|
|
PIP5K1A
|
[NCBI]
|
1.59018e-05
|
|
|
WISP1
|
[NCBI]
|
1.59018e-05
|
|
|
PWCR1
|
[NCBI]
|
1.59018e-05
|
|
|
RND1
|
[NCBI]
|
1.59018e-05
|
|
|
BOC
|
[NCBI]
|
1.59018e-05
|
|
|
CLDN5
|
[NCBI]
|
1.59018e-05
|
|
|
DGCR6
|
[NCBI]
|
1.59018e-05
|
|
|
IPW
|
[NCBI]
|
1.59018e-05
|
|
|
NSMAF
|
[NCBI]
|
1.59018e-05
|
|
|
CTAG2
|
[NCBI]
|
1.59018e-05
|
|
|
DGKG
|
[NCBI]
|
1.59018e-05
|
|
|
EXOSC7
|
[NCBI]
|
1.59018e-05
|
|
|
ZNF267
|
[NCBI]
|
1.59018e-05
|
|
|
HOXB1
|
[NCBI]
|
1.59018e-05
|
|
|
IRAK1
|
[NCBI]
|
1.59018e-05
|
|
|
SH3BP2
|
[NCBI]
|
1.59018e-05
|
|
|
PDE3A
|
[NCBI]
|
1.59018e-05
|
|
|
deleted in endometrial carcinoma
|
[NCBI]
|
1.59018e-05
|
|
|
CNTN1
|
[NCBI]
|
1.59018e-05
|
|
|
MYBL1
|
[NCBI]
|
1.59018e-05
|
|
|
TNFAIP6
|
[NCBI]
|
1.59018e-05
|
|
|
NKX2C
|
[NCBI]
|
1.59018e-05
|
|
|
DMRT2
|
[NCBI]
|
1.59018e-05
|
|
|
CHAF1B
|
[NCBI]
|
1.59018e-05
|
|
|
NPAS3
|
[NCBI]
|
1.59018e-05
|
|
|
USP25
|
[NCBI]
|
1.59018e-05
|
|
|
SGPL1
|
[NCBI]
|
1.59018e-05
|
|
|
FOXD1
|
[NCBI]
|
1.59018e-05
|
|
|
RCE1
|
[NCBI]
|
1.59018e-05
|
|
|
PCBP4
|
[NCBI]
|
1.59018e-05
|
|
|
FLRT3
|
[NCBI]
|
1.59018e-05
|
|
|
HYAL3
|
[NCBI]
|
1.59018e-05
|
|
|
XAB1
|
[NCBI]
|
1.59018e-05
|
|
|
CYP2G1
|
[NCBI]
|
1.59018e-05
|
|
|
alpha-thalassemia/mental retardation syndrome, deletion-type
|
[NCBI]
|
1.57992e-05
|
|
|
dent disease 1
|
[NCBI]
|
1.57992e-05
|
|
|
SCZD4
|
[NCBI]
|
1.57992e-05
|
|
|
glutaric acidemia i
|
[NCBI]
|
1.57992e-05
|
|
|
propionic acidemia
|
[NCBI]
|
1.57992e-05
|
|
|
holocarboxylase synthetase deficiency
|
[NCBI]
|
1.57992e-05
|
|
|
MTS
|
[NCBI]
|
1.57992e-05
|
|
|
complement factor h deficiency
|
[NCBI]
|
1.57992e-05
|
|
|
ichthyosis congenita, harlequin fetus type
|
[NCBI]
|
1.57992e-05
|
|
|
danon disease
|
[NCBI]
|
1.57992e-05
|
|
|
heterotopia, periventricular, x-linked dominant
|
[NCBI]
|
1.57992e-05
|
|
|
COL2A1
|
[NCBI]
|
1.57677e-05
|
|
|
CLCN5
|
[NCBI]
|
1.56534e-05
|
|
|
GJB6
|
[NCBI]
|
1.56534e-05
|
|
|
PEX7
|
[NCBI]
|
1.56534e-05
|
|
|
TDG
|
[NCBI]
|
1.56534e-05
|
|
|
MEN1
|
[NCBI]
|
1.53806e-05
|
|
|
HGF
|
[NCBI]
|
1.5229e-05
|
|
|
ABCC2
|
[NCBI]
|
1.51912e-05
|
|
|
FOXC2
|
[NCBI]
|
1.51619e-05
|
|
|
ASIP
|
[NCBI]
|
1.51619e-05
|
|
|
DKC1
|
[NCBI]
|
1.51619e-05
|
|
|
DBA
|
[NCBI]
|
1.48922e-05
|
|
|
MSH2
|
[NCBI]
|
1.48675e-05
|
|
|
GAPDH
|
[NCBI]
|
1.48358e-05
|
|
|
TTP
|
[NCBI]
|
1.47462e-05
|
|
|
PFM
|
[NCBI]
|
1.47462e-05
|
|
|
robinow syndrome, autosomal recessive
|
[NCBI]
|
1.47462e-05
|
|
|
PFIC1
|
[NCBI]
|
1.47462e-05
|
|
|
pyruvate carboxylase deficiency
|
[NCBI]
|
1.47462e-05
|
|
|
HSAN2
|
[NCBI]
|
1.47462e-05
|
|
|
PARK6
|
[NCBI]
|
1.47462e-05
|
|
|
CPI
|
[NCBI]
|
1.43533e-05
|
|
|
AR
|
[NCBI]
|
1.43207e-05
|
|
|
AIRE
|
[NCBI]
|
1.42825e-05
|
|
|
EDA
|
[NCBI]
|
1.42508e-05
|
|
|
SLC25A20
|
[NCBI]
|
1.42508e-05
|
|
|
hurler syndrome
|
[NCBI]
|
1.42463e-05
|
|
|
GH1
|
[NCBI]
|
1.41081e-05
|
|
|
CRYZ
|
[NCBI]
|
1.39426e-05
|
|
|
MADCAM1
|
[NCBI]
|
1.39426e-05
|
|
|
DYRK3
|
[NCBI]
|
1.39426e-05
|
|
|
DSCR2
|
[NCBI]
|
1.39426e-05
|
|
|
CSRP3
|
[NCBI]
|
1.39426e-05
|
|
|
MAT2A
|
[NCBI]
|
1.39426e-05
|
|
|
PLCG2
|
[NCBI]
|
1.39426e-05
|
|
|
ALG3
|
[NCBI]
|
1.39426e-05
|
|
|
SFRS8
|
[NCBI]
|
1.39426e-05
|
|
|
JMJD3
|
[NCBI]
|
1.39426e-05
|
|
|
ARHGAP8
|
[NCBI]
|
1.39426e-05
|
|
|
CRELD1
|
[NCBI]
|
1.39426e-05
|
|
|
SSNA1
|
[NCBI]
|
1.39426e-05
|
|
|
RBM6
|
[NCBI]
|
1.39426e-05
|
|
|
HOMER3
|
[NCBI]
|
1.39426e-05
|
|
|
FDFT1
|
[NCBI]
|
1.39426e-05
|
|
|
IK
|
[NCBI]
|
1.39426e-05
|
|
|
LIPH
|
[NCBI]
|
1.39426e-05
|
|
|
FKBP6
|
[NCBI]
|
1.39426e-05
|
|
|
pejvakin
|
[NCBI]
|
1.39426e-05
|
|
|
PDE7A
|
[NCBI]
|
1.39426e-05
|
|
|
HCCS
|
[NCBI]
|
1.39426e-05
|
|
|
RNGTT
|
[NCBI]
|
1.39426e-05
|
|
|
NUDC
|
[NCBI]
|
1.39426e-05
|
|
|
DDX21
|
[NCBI]
|
1.39426e-05
|
|
|
LUC7L
|
[NCBI]
|
1.39426e-05
|
|
|
NDUFB6
|
[NCBI]
|
1.39426e-05
|
|
|
GPAM
|
[NCBI]
|
1.39426e-05
|
|
|
UGT1A9
|
[NCBI]
|
1.39426e-05
|
|
|
TINF2
|
[NCBI]
|
1.39426e-05
|
|
|
SLC25A15
|
[NCBI]
|
1.39426e-05
|
|
|
PPAP2C
|
[NCBI]
|
1.39426e-05
|
|
|
NDUFA1
|
[NCBI]
|
1.39426e-05
|
|
|
CDH12
|
[NCBI]
|
1.39426e-05
|
|
|
GATA5
|
[NCBI]
|
1.39426e-05
|
|
|
PIGB
|
[NCBI]
|
1.39426e-05
|
|
|
CSNK1D
|
[NCBI]
|
1.39426e-05
|
|
|
NELF
|
[NCBI]
|
1.39426e-05
|
|
|
BCL2L10
|
[NCBI]
|
1.39426e-05
|
|
|
SLC12A6
|
[NCBI]
|
1.39426e-05
|
|
|
CLN5
|
[NCBI]
|
1.39426e-05
|
|
|
VIPR2
|
[NCBI]
|
1.39426e-05
|
|
|
MTTY
|
[NCBI]
|
1.39426e-05
|
|
|
MYOM2
|
[NCBI]
|
1.39426e-05
|
|
|
ETFB
|
[NCBI]
|
1.39426e-05
|
|
|
MIRN1-2
|
[NCBI]
|
1.39426e-05
|
|
|
DYRK2
|
[NCBI]
|
1.39426e-05
|
|
|
CHRM2
|
[NCBI]
|
1.39426e-05
|
|
|
COIL
|
[NCBI]
|
1.39426e-05
|
|
|
CEP2
|
[NCBI]
|
1.39426e-05
|
|
|
TIAF1
|
[NCBI]
|
1.39426e-05
|
|
|
PSMC4
|
[NCBI]
|
1.39426e-05
|
|
|
SOX18
|
[NCBI]
|
1.39426e-05
|
|
|
UIMC1
|
[NCBI]
|
1.39426e-05
|
|
|
STAT5A
|
[NCBI]
|
1.39246e-05
|
|
|
MYO5A
|
[NCBI]
|
1.38273e-05
|
|
|
MIP
|
[NCBI]
|
1.38273e-05
|
|
|
MTCO3
|
[NCBI]
|
1.38273e-05
|
|
|
NKX2E
|
[NCBI]
|
1.38273e-05
|
|
|
PHA
|
[NCBI]
|
1.37768e-05
|
|
|
DYX2
|
[NCBI]
|
1.37768e-05
|
|
|
CORD2
|
[NCBI]
|
1.37768e-05
|
|
|
diabetes-deafness syndrome, maternally transmitted
|
[NCBI]
|
1.37768e-05
|
|
|
blood group, p system
|
[NCBI]
|
1.37768e-05
|
|
|
AHDS
|
[NCBI]
|
1.37768e-05
|
|
|
SPCH1
|
[NCBI]
|
1.37768e-05
|
|
|
mucopolysaccharidosis type iiia
|
[NCBI]
|
1.37768e-05
|
|
|
TMAU
|
[NCBI]
|
1.37768e-05
|
|
|
CIPA
|
[NCBI]
|
1.37768e-05
|
|
|
SCZD
|
[NCBI]
|
1.35594e-05
|
|
|
TSD
|
[NCBI]
|
1.34618e-05
|
|
|
GNAS
|
[NCBI]
|
1.34334e-05
|
|
|
PAX2
|
[NCBI]
|
1.34228e-05
|
|
|
GALC
|
[NCBI]
|
1.34228e-05
|
|
|
CDKN1C
|
[NCBI]
|
1.34228e-05
|
|
|
PKD2
|
[NCBI]
|
1.34096e-05
|
|
|
BPES
|
[NCBI]
|
1.33289e-05
|
|
|
TF
|
[NCBI]
|
1.32969e-05
|
|
|
SLC22A5
|
[NCBI]
|
1.3036e-05
|
|
|
CRYAB
|
[NCBI]
|
1.3036e-05
|
|
|
OPA1
|
[NCBI]
|
1.3036e-05
|
|
|
COL4A3
|
[NCBI]
|
1.3036e-05
|
|
|
EYA1
|
[NCBI]
|
1.3036e-05
|
|
|
MB
|
[NCBI]
|
1.29245e-05
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
1.28813e-05
|
|
|
EA2
|
[NCBI]
|
1.28813e-05
|
|
|
GABEB
|
[NCBI]
|
1.28813e-05
|
|
|
SHEP2
|
[NCBI]
|
1.28813e-05
|
|
|
weaver syndrome
|
[NCBI]
|
1.28813e-05
|
|
|
SRF
|
[NCBI]
|
1.27584e-05
|
|
|
CHRNE
|
[NCBI]
|
1.26655e-05
|
|
|
MUT
|
[NCBI]
|
1.26655e-05
|
|
|
INPP5D
|
[NCBI]
|
1.26655e-05
|
|
|
TNNT2
|
[NCBI]
|
1.26655e-05
|
|
|
contractural arachnodactyly, congenital
|
[NCBI]
|
1.26655e-05
|
|
|
IFNGR1
|
[NCBI]
|
1.26655e-05
|
|
|
BIRC1
|
[NCBI]
|
1.25344e-05
|
|
|
ERMAP
|
[NCBI]
|
1.25019e-05
|
|
|
SIN3A
|
[NCBI]
|
1.25019e-05
|
|
|
PALB2
|
[NCBI]
|
1.25019e-05
|
|
|
multiple coagulation factor deficiency protein 2
|
[NCBI]
|
1.25019e-05
|
|
|
SART1
|
[NCBI]
|
1.25019e-05
|
|
|
YWHAB
|
[NCBI]
|
1.25019e-05
|
|
|
MAGEE1
|
[NCBI]
|
1.25019e-05
|
|
|
ADRA2B
|
[NCBI]
|
1.25019e-05
|
|
|
OSTM1
|
[NCBI]
|
1.25019e-05
|
|
|
MYOG
|
[NCBI]
|
1.25019e-05
|
|
|
CATSPER2
|
[NCBI]
|
1.25019e-05
|
|
|
SKIIP
|
[NCBI]
|
1.25019e-05
|
|
|
IKZF3
|
[NCBI]
|
1.25019e-05
|
|
|
KIF4A
|
[NCBI]
|
1.25019e-05
|
|
|
OSBPL3
|
[NCBI]
|
1.25019e-05
|
|
|
CLCNKA
|
[NCBI]
|
1.25019e-05
|
|
|
RGS8
|
[NCBI]
|
1.25019e-05
|
|
|
HYAL1
|
[NCBI]
|
1.25019e-05
|
|
|
CCM2
|
[NCBI]
|
1.25019e-05
|
|
|
AP3B2
|
[NCBI]
|
1.25019e-05
|
|
|
TNKS
|
[NCBI]
|
1.25019e-05
|
|
|
EMILIN1
|
[NCBI]
|
1.25019e-05
|
|
|
BCAP31
|
[NCBI]
|
1.25019e-05
|
|
|
DCDC2
|
[NCBI]
|
1.25019e-05
|
|
|
NBEA
|
[NCBI]
|
1.25019e-05
|
|
|
SDCBP
|
[NCBI]
|
1.25019e-05
|
|
|
PCBP1
|
[NCBI]
|
1.25019e-05
|
|
|
ACADSB
|
[NCBI]
|
1.25019e-05
|
|
|
HOXB7
|
[NCBI]
|
1.25019e-05
|
|
|
STRC
|
[NCBI]
|
1.25019e-05
|
|
|
EIF4A1
|
[NCBI]
|
1.25019e-05
|
|
|
BFSP1
|
[NCBI]
|
1.25019e-05
|
|
|
NDUFV1
|
[NCBI]
|
1.25019e-05
|
|
|
ABCA12
|
[NCBI]
|
1.25019e-05
|
|
|
GPR56
|
[NCBI]
|
1.25019e-05
|
|
|
DPM1
|
[NCBI]
|
1.25019e-05
|
|
|
KCNK3
|
[NCBI]
|
1.25019e-05
|
|
|
C1S
|
[NCBI]
|
1.25019e-05
|
|
|
AMHR2
|
[NCBI]
|
1.25019e-05
|
|
|
RBM5
|
[NCBI]
|
1.25019e-05
|
|
|
PRDM2
|
[NCBI]
|
1.25019e-05
|
|
|
CSNK1E
|
[NCBI]
|
1.25019e-05
|
|
|
PIP5K1B
|
[NCBI]
|
1.25019e-05
|
|
|
NTHL1
|
[NCBI]
|
1.25019e-05
|
|
|
PLA2G6
|
[NCBI]
|
1.25019e-05
|
|
|
SHOX2
|
[NCBI]
|
1.25019e-05
|
|
|
CHML
|
[NCBI]
|
1.25019e-05
|
|
|
CUL7
|
[NCBI]
|
1.25019e-05
|
|
|
TNFRSF17
|
[NCBI]
|
1.25019e-05
|
|
|
ITGAE
|
[NCBI]
|
1.25019e-05
|
|
|
EIF4B
|
[NCBI]
|
1.25019e-05
|
|
|
MEF2D
|
[NCBI]
|
1.25019e-05
|
|
|
HDAC1
|
[NCBI]
|
1.24853e-05
|
|
|
SLC6A3
|
[NCBI]
|
1.23463e-05
|
|
|
CD36
|
[NCBI]
|
1.23264e-05
|
|
|
NOG
|
[NCBI]
|
1.23102e-05
|
|
|
IGF2R
|
[NCBI]
|
1.23102e-05
|
|
|
KRT14
|
[NCBI]
|
1.23102e-05
|
|
|
SPP1
|
[NCBI]
|
1.21595e-05
|
|
|
HIDS
|
[NCBI]
|
1.20513e-05
|
|
|
KAL2
|
[NCBI]
|
1.20513e-05
|
|
|
JBS
|
[NCBI]
|
1.20513e-05
|
|
|
CBAVD
|
[NCBI]
|
1.20513e-05
|
|
|
pseudohypoparathyroidism, type ib
|
[NCBI]
|
1.20513e-05
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
1.20513e-05
|
|
|
XPC
|
[NCBI]
|
1.19692e-05
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
1.19223e-05
|
|
|
CNTF
|
[NCBI]
|
1.18776e-05
|
|
|
IP
|
[NCBI]
|
1.17403e-05
|
|
|
prostate cancer
|
[NCBI]
|
1.16496e-05
|
|
|
CSTB
|
[NCBI]
|
1.16413e-05
|
|
|
TGFBR2
|
[NCBI]
|
1.16413e-05
|
|
|
MSH6
|
[NCBI]
|
1.16413e-05
|
|
|
PRODH
|
[NCBI]
|
1.16413e-05
|
|
|
DLG3
|
[NCBI]
|
1.13664e-05
|
|
|
IFRD1
|
[NCBI]
|
1.13664e-05
|
|
|
TRIP11
|
[NCBI]
|
1.13664e-05
|
|
|
CDC2L2
|
[NCBI]
|
1.13664e-05
|
|
|
IGF2BP1
|
[NCBI]
|
1.13664e-05
|
|
|
SYNJ1
|
[NCBI]
|
1.13664e-05
|
|
|
CTCFL
|
[NCBI]
|
1.13664e-05
|
|
|
HSN2
|
[NCBI]
|
1.13664e-05
|
|
|
EHD1
|
[NCBI]
|
1.13664e-05
|
|
|
humanin
|
[NCBI]
|
1.13664e-05
|
|
|
RPL22
|
[NCBI]
|
1.13664e-05
|
|
|
ARMET
|
[NCBI]
|
1.13664e-05
|
|
|
CFC1
|
[NCBI]
|
1.13664e-05
|
|
|
FANCM
|
[NCBI]
|
1.13664e-05
|
|
|
COX10
|
[NCBI]
|
1.13664e-05
|
|
|
PON3
|
[NCBI]
|
1.13664e-05
|
|
|
DDX20
|
[NCBI]
|
1.13664e-05
|
|
|
PMS1
|
[NCBI]
|
1.13664e-05
|
|
|
HOMER2
|
[NCBI]
|
1.13664e-05
|
|
|
TALDO1
|
[NCBI]
|
1.13664e-05
|
|
|
TOPORS
|
[NCBI]
|
1.13664e-05
|
|
|
GCN5L2
|
[NCBI]
|
1.13664e-05
|
|
|
SLC9A3R1
|
[NCBI]
|
1.13664e-05
|
|
|
NDEL1
|
[NCBI]
|
1.13664e-05
|
|
|
HELLS
|
[NCBI]
|
1.13664e-05
|
|
|
SLC22A3
|
[NCBI]
|
1.13664e-05
|
|
|
MTTN
|
[NCBI]
|
1.13664e-05
|
|
|
DLX3
|
[NCBI]
|
1.13664e-05
|
|
|
SUMF1
|
[NCBI]
|
1.13664e-05
|
|
|
OAZ1
|
[NCBI]
|
1.13664e-05
|
|
|
GJC2
|
[NCBI]
|
1.13664e-05
|
|
|
STX11
|
[NCBI]
|
1.13664e-05
|
|
|
GRK1
|
[NCBI]
|
1.13664e-05
|
|
|
NDUFS1
|
[NCBI]
|
1.13664e-05
|
|
|
DEFB103A
|
[NCBI]
|
1.13664e-05
|
|
|
GLI2
|
[NCBI]
|
1.13664e-05
|
|
|
CDAN1
|
[NCBI]
|
1.13664e-05
|
|
|
ABCG1
|
[NCBI]
|
1.13664e-05
|
|
|
BOP1
|
[NCBI]
|
1.13664e-05
|
|
|
FXR2
|
[NCBI]
|
1.13664e-05
|
|
|
E4F1
|
[NCBI]
|
1.13664e-05
|
|
|
GPRK2L
|
[NCBI]
|
1.13664e-05
|
|
|
THBS3
|
[NCBI]
|
1.13664e-05
|
|
|
POU4F3
|
[NCBI]
|
1.13664e-05
|
|
|
ARID4A
|
[NCBI]
|
1.13664e-05
|
|
|
PHF9
|
[NCBI]
|
1.13664e-05
|
|
|
hemophilia a
|
[NCBI]
|
1.13494e-05
|
|
|
GLI3
|
[NCBI]
|
1.13259e-05
|
|
|
CAPN3
|
[NCBI]
|
1.13259e-05
|
|
|
COL6A1
|
[NCBI]
|
1.13259e-05
|
|
|
refsum disease, infantile form
|
[NCBI]
|
1.128e-05
|
|
|
PLOSL
|
[NCBI]
|
1.128e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
1.128e-05
|
|
|
ORW2
|
[NCBI]
|
1.128e-05
|
|
|
CFLAR
|
[NCBI]
|
1.10221e-05
|
|
|
COL10A1
|
[NCBI]
|
1.10221e-05
|
|
|
FRAP1
|
[NCBI]
|
1.09161e-05
|
|
|
porphyria variegata
|
[NCBI]
|
1.08807e-05
|
|
|
MODY
|
[NCBI]
|
1.0815e-05
|
|
|
SLC4A1
|
[NCBI]
|
1.07981e-05
|
|
|
CLCN1
|
[NCBI]
|
1.07292e-05
|
|
|
CYBB
|
[NCBI]
|
1.07292e-05
|
|
|
SOX10
|
[NCBI]
|
1.07292e-05
|
|
|
pfeiffer syndrome
|
[NCBI]
|
1.05614e-05
|
|
|
BDKRB1
|
[NCBI]
|
1.04327e-05
|
|
|
CLCN3
|
[NCBI]
|
1.04327e-05
|
|
|
WHSC2
|
[NCBI]
|
1.04327e-05
|
|
|
ESPN
|
[NCBI]
|
1.04327e-05
|
|
|
CDKN2D
|
[NCBI]
|
1.04327e-05
|
|
|
IL5RA
|
[NCBI]
|
1.04327e-05
|
|
|
FUSIP1
|
[NCBI]
|
1.04327e-05
|
|
|
CDON
|
[NCBI]
|
1.04327e-05
|
|
|
FIP1L1
|
[NCBI]
|
1.04327e-05
|
|
|
P4HA1
|
[NCBI]
|
1.04327e-05
|
|
|
CHD7
|
[NCBI]
|
1.04327e-05
|
|
|
KCNN4
|
[NCBI]
|
1.04327e-05
|
|
|
PHKB
|
[NCBI]
|
1.04327e-05
|
|
|
TAS2R10
|
[NCBI]
|
1.04327e-05
|
|
|
GRIN2C
|
[NCBI]
|
1.04327e-05
|
|
|
CHRNB1
|
[NCBI]
|
1.04327e-05
|
|
|
TRPM1
|
[NCBI]
|
1.04327e-05
|
|
|
P2RX1
|
[NCBI]
|
1.04327e-05
|
|
|
NCOA4
|
[NCBI]
|
1.04327e-05
|
|
|
NDUFS8
|
[NCBI]
|
1.04327e-05
|
|
|
CACNA2D1
|
[NCBI]
|
1.04327e-05
|
|
|
AKAP13
|
[NCBI]
|
1.04327e-05
|
|
|
NFIA
|
[NCBI]
|
1.04327e-05
|
|
|
WNT2
|
[NCBI]
|
1.04327e-05
|
|
|
PRSS12
|
[NCBI]
|
1.04327e-05
|
|
|
PTPRN
|
[NCBI]
|
1.04327e-05
|
|
|
PCDH11Y
|
[NCBI]
|
1.04327e-05
|
|
|
SUFU
|
[NCBI]
|
1.04327e-05
|
|
|
FNBP1
|
[NCBI]
|
1.04327e-05
|
|
|
NSDHL
|
[NCBI]
|
1.04327e-05
|
|
|
PPP1R3A
|
[NCBI]
|
1.04327e-05
|
|
|
NHLRC1
|
[NCBI]
|
1.04327e-05
|
|
|
PCAF
|
[NCBI]
|
1.04327e-05
|
|
|
IL15RA
|
[NCBI]
|
1.04327e-05
|
|
|
PCDH11X
|
[NCBI]
|
1.04327e-05
|
|
|
ACVR1B
|
[NCBI]
|
1.04327e-05
|
|
|
MBD1
|
[NCBI]
|
1.04327e-05
|
|
|
PTPN13
|
[NCBI]
|
1.04327e-05
|
|
|
GPX2
|
[NCBI]
|
1.04327e-05
|
|
|
UCHL3
|
[NCBI]
|
1.04327e-05
|
|
|
GHRH
|
[NCBI]
|
1.03065e-05
|
|
|
FHIT
|
[NCBI]
|
1.01738e-05
|
|
|
TYRP1
|
[NCBI]
|
1.01738e-05
|
|
|
NDP
|
[NCBI]
|
9.91016e-06
|
|
|
NR6A1
|
[NCBI]
|
9.91016e-06
|
|
|
MYO7A
|
[NCBI]
|
9.91016e-06
|
|
|
PTHR1
|
[NCBI]
|
9.91016e-06
|
|
|
HDAC3
|
[NCBI]
|
9.91016e-06
|
|
|
BCL6
|
[NCBI]
|
9.91016e-06
|
|
|
aortic aneurysm, abdominal
|
[NCBI]
|
9.8907e-06
|
|
|
faciogenital dysplasia
|
[NCBI]
|
9.8907e-06
|
|
|
mannosidosis, alpha b, lysosomal
|
[NCBI]
|
9.8907e-06
|
|
|
RTD
|
[NCBI]
|
9.8907e-06
|
|
|
MDC1A
|
[NCBI]
|
9.8907e-06
|
|
|
fraser syndrome
|
[NCBI]
|
9.8907e-06
|
|
|
megaloblastic anemia 1
|
[NCBI]
|
9.8907e-06
|
|
|
HBA2
|
[NCBI]
|
9.79108e-06
|
|
|
XPA
|
[NCBI]
|
9.65523e-06
|
|
|
GK
|
[NCBI]
|
9.65523e-06
|
|
|
RAG1
|
[NCBI]
|
9.65523e-06
|
|
|
RAD51L3
|
[NCBI]
|
9.6423e-06
|
|
|
NLGN3
|
[NCBI]
|
9.6423e-06
|
|
|
DVL2
|
[NCBI]
|
9.6423e-06
|
|
|
HLXB9
|
[NCBI]
|
9.6423e-06
|
|
|
LPIN2
|
[NCBI]
|
9.6423e-06
|
|
|
SMAD1
|
[NCBI]
|
9.6423e-06
|
|
|
APLP1
|
[NCBI]
|
9.6423e-06
|
|
|
GOPC
|
[NCBI]
|
9.6423e-06
|
|
|
IFNGR2
|
[NCBI]
|
9.6423e-06
|
|
|
TRPM7
|
[NCBI]
|
9.6423e-06
|
|
|
PEX6
|
[NCBI]
|
9.6423e-06
|
|
|
GNS
|
[NCBI]
|
9.6423e-06
|
|
|
UNC13B
|
[NCBI]
|
9.6423e-06
|
|
|
PIP5K1C
|
[NCBI]
|
9.6423e-06
|
|
|
LGR8
|
[NCBI]
|
9.6423e-06
|
|
|
CSRP1
|
[NCBI]
|
9.6423e-06
|
|
|
MIRN1-1
|
[NCBI]
|
9.6423e-06
|
|
|
SNX9
|
[NCBI]
|
9.6423e-06
|
|
|
NNT
|
[NCBI]
|
9.6423e-06
|
|
|
CRYBB1
|
[NCBI]
|
9.6423e-06
|
|
|
VRK1
|
[NCBI]
|
9.6423e-06
|
|
|
CHIT1
|
[NCBI]
|
9.6423e-06
|
|
|
PODXL
|
[NCBI]
|
9.6423e-06
|
|
|
TM4SF2
|
[NCBI]
|
9.6423e-06
|
|
|
CLDN14
|
[NCBI]
|
9.6423e-06
|
|
|
CENPJ
|
[NCBI]
|
9.6423e-06
|
|
|
NDUFA13
|
[NCBI]
|
9.6423e-06
|
|
|
YWHAE
|
[NCBI]
|
9.6423e-06
|
|
|
SLC7A7
|
[NCBI]
|
9.6423e-06
|
|
|
PSMC3
|
[NCBI]
|
9.6423e-06
|
|
|
HES1
|
[NCBI]
|
9.6423e-06
|
|
|
TAC1
|
[NCBI]
|
9.6423e-06
|
|
|
FSCN2
|
[NCBI]
|
9.6423e-06
|
|
|
SDHA
|
[NCBI]
|
9.6423e-06
|
|
|
MAPK8IP3
|
[NCBI]
|
9.6423e-06
|
|
|
WBSCR5
|
[NCBI]
|
9.6423e-06
|
|
|
KRT4
|
[NCBI]
|
9.6423e-06
|
|
|
INADL
|
[NCBI]
|
9.6423e-06
|
|
|
CYP4A11
|
[NCBI]
|
9.6423e-06
|
|
|
POU3F1
|
[NCBI]
|
9.6423e-06
|
|
|
ACVR2B
|
[NCBI]
|
9.6423e-06
|
|
|
FANCC
|
[NCBI]
|
9.40854e-06
|
|
|
RECQL2
|
[NCBI]
|
9.40854e-06
|
|
|
PTPRC
|
[NCBI]
|
9.40854e-06
|
|
|
wolman disease
|
[NCBI]
|
9.40854e-06
|
|
|
SLOS
|
[NCBI]
|
9.39957e-06
|
|
|
MLC
|
[NCBI]
|
9.26337e-06
|
|
|
MADD
|
[NCBI]
|
9.26337e-06
|
|
|
bartter syndrome, type 3
|
[NCBI]
|
9.26337e-06
|
|
|
DRD
|
[NCBI]
|
9.26337e-06
|
|
|
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
|
[NCBI]
|
9.26337e-06
|
|
|
GIP
|
[NCBI]
|
9.22381e-06
|
|
|
PKLR
|
[NCBI]
|
9.16968e-06
|
|
|
DSG1
|
[NCBI]
|
9.16968e-06
|
|
|
ATF2
|
[NCBI]
|
9.16968e-06
|
|
|
EDNRB
|
[NCBI]
|
9.16968e-06
|
|
|
menkes disease
|
[NCBI]
|
9.14139e-06
|
|
|
DDC
|
[NCBI]
|
9.09986e-06
|
|
|
PLD1
|
[NCBI]
|
8.95915e-06
|
|
|
FUT4
|
[NCBI]
|
8.95915e-06
|
|
|
ST7
|
[NCBI]
|
8.95915e-06
|
|
|
FGF14
|
[NCBI]
|
8.95915e-06
|
|
|
RABAC1
|
[NCBI]
|
8.95915e-06
|
|
|
TOP3A
|
[NCBI]
|
8.95915e-06
|
|
|
NOTCH2
|
[NCBI]
|
8.95915e-06
|
|
|
POR
|
[NCBI]
|
8.95915e-06
|
|
|
LAMC2
|
[NCBI]
|
8.95915e-06
|
|
|
NUMBL
|
[NCBI]
|
8.95915e-06
|
|
|
RBL1
|
[NCBI]
|
8.95915e-06
|
|
|
OPHN1
|
[NCBI]
|
8.95915e-06
|
|
|
RAD21
|
[NCBI]
|
8.95915e-06
|
|
|
DSC2
|
[NCBI]
|
8.95915e-06
|
|
|
GPD2
|
[NCBI]
|
8.95915e-06
|
|
|
ROCK1
|
[NCBI]
|
8.95915e-06
|
|
|
CDC2L1
|
[NCBI]
|
8.95915e-06
|
|
|
TDGF1
|
[NCBI]
|
8.95915e-06
|
|
|
BCKDHB
|
[NCBI]
|
8.95915e-06
|
|
|
PEX13
|
[NCBI]
|
8.95915e-06
|
|
|
SP1
|
[NCBI]
|
8.95915e-06
|
|
|
MTRR
|
[NCBI]
|
8.95915e-06
|
|
|
ARD1A
|
[NCBI]
|
8.95915e-06
|
|
|
CYR61
|
[NCBI]
|
8.95915e-06
|
|
|
HOMER1
|
[NCBI]
|
8.95915e-06
|
|
|
CLCNKB
|
[NCBI]
|
8.95915e-06
|
|
|
CTAG1B
|
[NCBI]
|
8.95915e-06
|
|
|
LMO7
|
[NCBI]
|
8.95915e-06
|
|
|
GRHPR
|
[NCBI]
|
8.95915e-06
|
|
|
DFNA5
|
[NCBI]
|
8.95915e-06
|
|
|
GTF2IRD1
|
[NCBI]
|
8.95915e-06
|
|
|
SLC34A1
|
[NCBI]
|
8.95915e-06
|
|
|
FCAR
|
[NCBI]
|
8.95915e-06
|
|
|
SMN2
|
[NCBI]
|
8.93826e-06
|
|
|
F3
|
[NCBI]
|
8.93459e-06
|
|
|
HIF1A
|
[NCBI]
|
8.71393e-06
|
|
|
protoporphyria, erythropoietic
|
[NCBI]
|
8.71393e-06
|
|
|
RMD
|
[NCBI]
|
8.67567e-06
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
8.67567e-06
|
|
|
CMM2
|
[NCBI]
|
8.67567e-06
|
|
|
hyperglycerolemia
|
[NCBI]
|
8.67567e-06
|
|
|
SCDO1
|
[NCBI]
|
8.67567e-06
|
|
|
ABCA4
|
[NCBI]
|
8.49636e-06
|
|
|
DSC1
|
[NCBI]
|
8.35922e-06
|
|
|
KCNJ6
|
[NCBI]
|
8.35922e-06
|
|
|
GSTT1
|
[NCBI]
|
8.35922e-06
|
|
|
RP1
|
[NCBI]
|
8.35922e-06
|
|
|
MLPH
|
[NCBI]
|
8.35922e-06
|
|
|
AGC1
|
[NCBI]
|
8.35922e-06
|
|
|
CDH3
|
[NCBI]
|
8.35922e-06
|
|
|
PCSK2
|
[NCBI]
|
8.35922e-06
|
|
|
WHSC1
|
[NCBI]
|
8.35922e-06
|
|
|
LMBR1
|
[NCBI]
|
8.35922e-06
|
|
|
ELOVL4
|
[NCBI]
|
8.35922e-06
|
|
|
MORF4
|
[NCBI]
|
8.35922e-06
|
|
|
SCN1B
|
[NCBI]
|
8.35922e-06
|
|
|
CASP9
|
[NCBI]
|
8.35922e-06
|
|
|
APOA5
|
[NCBI]
|
8.35922e-06
|
|
|
S100A10
|
[NCBI]
|
8.35922e-06
|
|
|
PSCD2
|
[NCBI]
|
8.35922e-06
|
|
|
A4GALT
|
[NCBI]
|
8.35922e-06
|
|
|
SETX
|
[NCBI]
|
8.35922e-06
|
|
|
XRCC1
|
[NCBI]
|
8.35922e-06
|
|
|
SYCP3
|
[NCBI]
|
8.35922e-06
|
|
|
CLDN16
|
[NCBI]
|
8.35922e-06
|
|
|
FGF5
|
[NCBI]
|
8.35922e-06
|
|
|
SCO2
|
[NCBI]
|
8.35922e-06
|
|
|
LARGE
|
[NCBI]
|
8.35922e-06
|
|
|
ATP8B1
|
[NCBI]
|
8.35922e-06
|
|
|
SOX4
|
[NCBI]
|
8.35922e-06
|
|
|
ZIC2
|
[NCBI]
|
8.35922e-06
|
|
|
GRB7
|
[NCBI]
|
8.35922e-06
|
|
|
LITAF
|
[NCBI]
|
8.35922e-06
|
|
|
FXR1
|
[NCBI]
|
8.35922e-06
|
|
|
DSG4
|
[NCBI]
|
8.35922e-06
|
|
|
AMT
|
[NCBI]
|
8.35922e-06
|
|
|
MAP3K1
|
[NCBI]
|
8.35922e-06
|
|
|
PABPN1
|
[NCBI]
|
8.35922e-06
|
|
|
GRID2
|
[NCBI]
|
8.35922e-06
|
|
|
farber lipogranulomatosis
|
[NCBI]
|
8.35922e-06
|
|
|
TACSTD2
|
[NCBI]
|
8.35922e-06
|
|
|
YWHAZ
|
[NCBI]
|
8.35922e-06
|
|
|
LMAN1
|
[NCBI]
|
8.35922e-06
|
|
|
GBA
|
[NCBI]
|
8.32446e-06
|
|
|
HEXB
|
[NCBI]
|
8.28522e-06
|
|
|
GLA
|
[NCBI]
|
8.28522e-06
|
|
|
COL1A2
|
[NCBI]
|
8.19075e-06
|
|
|
GJA1
|
[NCBI]
|
8.16397e-06
|
|
|
CFNS
|
[NCBI]
|
8.1243e-06
|
|
|
PBD
|
[NCBI]
|
8.1243e-06
|
|
|
MRXHF1
|
[NCBI]
|
8.1243e-06
|
|
|
hyperekplexia, hereditary
|
[NCBI]
|
8.1243e-06
|
|
|
gaucher disease, type iii
|
[NCBI]
|
8.1243e-06
|
|
|
FDH
|
[NCBI]
|
8.1243e-06
|
|
|
SEDC
|
[NCBI]
|
8.1243e-06
|
|
|
PABPC1
|
[NCBI]
|
8.05917e-06
|
|
|
STAT1
|
[NCBI]
|
7.9486e-06
|
|
|
REST
|
[NCBI]
|
7.88113e-06
|
|
|
KAL1
|
[NCBI]
|
7.88113e-06
|
|
|
RUNX1
|
[NCBI]
|
7.88113e-06
|
|
|
NXF1
|
[NCBI]
|
7.82575e-06
|
|
|
NEUROD1
|
[NCBI]
|
7.82575e-06
|
|
|
RPA1
|
[NCBI]
|
7.82575e-06
|
|
|
SLC17A5
|
[NCBI]
|
7.82575e-06
|
|
|
VAV1
|
[NCBI]
|
7.82575e-06
|
|
|
RIPK2
|
[NCBI]
|
7.82575e-06
|
|
|
LAMA3
|
[NCBI]
|
7.82575e-06
|
|
|
TYROBP
|
[NCBI]
|
7.82575e-06
|
|
|
RORC
|
[NCBI]
|
7.82575e-06
|
|
|
GLI
|
[NCBI]
|
7.82575e-06
|
|
|
LRP6
|
[NCBI]
|
7.82575e-06
|
|
|
PRND
|
[NCBI]
|
7.82575e-06
|
|
|
INPPL1
|
[NCBI]
|
7.82575e-06
|
|
|
SMAD7
|
[NCBI]
|
7.82575e-06
|
|
|
HOXA1
|
[NCBI]
|
7.82575e-06
|
|
|
COL15A1
|
[NCBI]
|
7.82575e-06
|
|
|
SLC22A2
|
[NCBI]
|
7.82575e-06
|
|
|
MXI1
|
[NCBI]
|
7.82575e-06
|
|
|
ERG
|
[NCBI]
|
7.82575e-06
|
|
|
CSPG2
|
[NCBI]
|
7.82575e-06
|
|
|
TRAF1
|
[NCBI]
|
7.82575e-06
|
|
|
TGIF
|
[NCBI]
|
7.82575e-06
|
|
|
KCNMB1
|
[NCBI]
|
7.82575e-06
|
|
|
RBBP8
|
[NCBI]
|
7.82575e-06
|
|
|
ATRX
|
[NCBI]
|
7.68765e-06
|
|
|
CCL21
|
[NCBI]
|
7.68765e-06
|
|
|
RELN
|
[NCBI]
|
7.68765e-06
|
|
|
lynch syndrome i
|
[NCBI]
|
7.63286e-06
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
7.60636e-06
|
|
|
SMA2
|
[NCBI]
|
7.60636e-06
|
|
|
OPRM1
|
[NCBI]
|
7.55331e-06
|
|
|
PRNP
|
[NCBI]
|
7.53189e-06
|
|
|
INS
|
[NCBI]
|
7.53134e-06
|
|
|
TPT1
|
[NCBI]
|
7.49956e-06
|
|
|
TNFRSF6
|
[NCBI]
|
7.49956e-06
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
7.49956e-06
|
|
|
TSC1
|
[NCBI]
|
7.49956e-06
|
|
|
MBL2
|
[NCBI]
|
7.48654e-06
|
|
|
POMC
|
[NCBI]
|
7.46064e-06
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
7.35597e-06
|
|
|
CXORF5
|
[NCBI]
|
7.34663e-06
|
|
|
MLC1
|
[NCBI]
|
7.34663e-06
|
|
|
PITX3
|
[NCBI]
|
7.34663e-06
|
|
|
NUMB
|
[NCBI]
|
7.34663e-06
|
|
|
JARID1C
|
[NCBI]
|
7.34663e-06
|
|
|
IGHMBP2
|
[NCBI]
|
7.34663e-06
|
|
|
HPS1
|
[NCBI]
|
7.34663e-06
|
|
|
ECGF1
|
[NCBI]
|
7.34663e-06
|
|
|
SOST
|
[NCBI]
|
7.34663e-06
|
|
|
PCBP2
|
[NCBI]
|
7.34663e-06
|
|
|
ZNF148
|
[NCBI]
|
7.34663e-06
|
|
|
DKK1
|
[NCBI]
|
7.34663e-06
|
|
|
KCNQ4
|
[NCBI]
|
7.34663e-06
|
|
|
TTPA
|
[NCBI]
|
7.34663e-06
|
|
|
SMARCA4
|
[NCBI]
|
7.34663e-06
|
|
|
IL12RB1
|
[NCBI]
|
7.34663e-06
|
|
|
TIMM8A
|
[NCBI]
|
7.34663e-06
|
|
|
PON2
|
[NCBI]
|
7.34663e-06
|
|
|
BFSP2
|
[NCBI]
|
7.34663e-06
|
|
|
PTEN
|
[NCBI]
|
7.28584e-06
|
|
|
DRPLA
|
[NCBI]
|
7.22609e-06
|
|
|
FGF7
|
[NCBI]
|
7.22117e-06
|
|
|
RASA1
|
[NCBI]
|
7.14286e-06
|
|
|
HCRT
|
[NCBI]
|
7.13868e-06
|
|
|
CTSL
|
[NCBI]
|
7.13868e-06
|
|
|
MLL
|
[NCBI]
|
7.13868e-06
|
|
|
HBFQTL1
|
[NCBI]
|
7.11927e-06
|
|
|
EVC
|
[NCBI]
|
7.11927e-06
|
|
|
FHM1
|
[NCBI]
|
7.11927e-06
|
|
|
factor vii deficiency
|
[NCBI]
|
6.96548e-06
|
|
|
NSEP1
|
[NCBI]
|
6.91274e-06
|
|
|
ATP2A1
|
[NCBI]
|
6.91274e-06
|
|
|
SALL4
|
[NCBI]
|
6.91274e-06
|
|
|
ASCL1
|
[NCBI]
|
6.91274e-06
|
|
|
F13B
|
[NCBI]
|
6.91274e-06
|
|
|
PTPN6
|
[NCBI]
|
6.91274e-06
|
|
|
PIN1
|
[NCBI]
|
6.91274e-06
|
|
|
WWOX
|
[NCBI]
|
6.91274e-06
|
|
|
NPC2
|
[NCBI]
|
6.91274e-06
|
|
|
GRM1
|
[NCBI]
|
6.91274e-06
|
|
|
COL6A2
|
[NCBI]
|
6.91274e-06
|
|
|
EZH2
|
[NCBI]
|
6.91274e-06
|
|
|
AEBP1
|
[NCBI]
|
6.91274e-06
|
|
|
G22P1
|
[NCBI]
|
6.91274e-06
|
|
|
CTBP1
|
[NCBI]
|
6.91274e-06
|
|
|
CTNNA1
|
[NCBI]
|
6.91274e-06
|
|
|
DYRK1A
|
[NCBI]
|
6.91274e-06
|
|
|
PRKAG2
|
[NCBI]
|
6.91274e-06
|
|
|
CDC25A
|
[NCBI]
|
6.91274e-06
|
|
|
STAT2
|
[NCBI]
|
6.91274e-06
|
|
|
ATP5O
|
[NCBI]
|
6.91274e-06
|
|
|
ICOS
|
[NCBI]
|
6.91274e-06
|
|
|
BLNK
|
[NCBI]
|
6.91274e-06
|
|
|
EMX2
|
[NCBI]
|
6.91274e-06
|
|
|
GFI1
|
[NCBI]
|
6.91274e-06
|
|
|
RAPGEF3
|
[NCBI]
|
6.91274e-06
|
|
|
SOX3
|
[NCBI]
|
6.91274e-06
|
|
|
ART4
|
[NCBI]
|
6.91274e-06
|
|
|
ICAM5
|
[NCBI]
|
6.91274e-06
|
|
|
KCNH2
|
[NCBI]
|
6.85978e-06
|
|
|
AHO
|
[NCBI]
|
6.82518e-06
|
|
|
MCP
|
[NCBI]
|
6.75661e-06
|
|
|
HP
|
[NCBI]
|
6.73239e-06
|
|
|
PF4
|
[NCBI]
|
6.69516e-06
|
|
|
neural tube defects
|
[NCBI]
|
6.66074e-06
|
|
|
HSAS
|
[NCBI]
|
6.66074e-06
|
|
|
BOR1
|
[NCBI]
|
6.66074e-06
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
6.66074e-06
|
|
|
CYP2D6
|
[NCBI]
|
6.63265e-06
|
|
|
F13A1
|
[NCBI]
|
6.63265e-06
|
|
|
SCN5A
|
[NCBI]
|
6.63265e-06
|
|
|
PSAP
|
[NCBI]
|
6.63265e-06
|
|
|
HSCR1
|
[NCBI]
|
6.59175e-06
|
|
|
GRIN2B
|
[NCBI]
|
6.51712e-06
|
|
|
MCOLN1
|
[NCBI]
|
6.51712e-06
|
|
|
FLI1
|
[NCBI]
|
6.51712e-06
|
|
|
MSX2
|
[NCBI]
|
6.51712e-06
|
|
|
KIF2C
|
[NCBI]
|
6.51712e-06
|
|
|
LDLRAP1
|
[NCBI]
|
6.51712e-06
|
|
|
SFTPA1
|
[NCBI]
|
6.51712e-06
|
|
|
RASSF1
|
[NCBI]
|
6.51712e-06
|
|
|
DDX58
|
[NCBI]
|
6.51712e-06
|
|
|
IKBKAP
|
[NCBI]
|
6.51712e-06
|
|
|
HLCS
|
[NCBI]
|
6.51712e-06
|
|
|
CYP3A5
|
[NCBI]
|
6.51712e-06
|
|
|
PXMP3
|
[NCBI]
|
6.51712e-06
|
|
|
EN2
|
[NCBI]
|
6.51712e-06
|
|
|
BLMH
|
[NCBI]
|
6.51712e-06
|
|
|
COL9A1
|
[NCBI]
|
6.51712e-06
|
|
|
SDHC
|
[NCBI]
|
6.51712e-06
|
|
|
MAT1A
|
[NCBI]
|
6.51712e-06
|
|
|
CDK5R1
|
[NCBI]
|
6.51712e-06
|
|
|
TFF2
|
[NCBI]
|
6.51712e-06
|
|
|
KCNJ1
|
[NCBI]
|
6.51712e-06
|
|
|
WNK4
|
[NCBI]
|
6.51712e-06
|
|
|
BCHE
|
[NCBI]
|
6.51506e-06
|
|
|
GALT
|
[NCBI]
|
6.47267e-06
|
|
|
LHCGR
|
[NCBI]
|
6.31677e-06
|
|
|
STGD1
|
[NCBI]
|
6.22873e-06
|
|
|
alzheimer disease 3
|
[NCBI]
|
6.22873e-06
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
6.22873e-06
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
6.22873e-06
|
|
|
ATRX
|
[NCBI]
|
6.22873e-06
|
|
|
OTC
|
[NCBI]
|
6.16481e-06
|
|
|
MYH7
|
[NCBI]
|
6.16481e-06
|
|
|
STARD3
|
[NCBI]
|
6.15428e-06
|
|
|
NDN
|
[NCBI]
|
6.15428e-06
|
|
|
FUT1
|
[NCBI]
|
6.15428e-06
|
|
|
DNAH11
|
[NCBI]
|
6.15428e-06
|
|
|
3-@hydroxy-3-methylglutaryl-coa lyase deficiency
|
[NCBI]
|
6.15428e-06
|
|
|
MNDA
|
[NCBI]
|
6.15428e-06
|
|
|
FSHB
|
[NCBI]
|
6.15428e-06
|
|
|
EFNB1
|
[NCBI]
|
6.15428e-06
|
|
|
BCKDHA
|
[NCBI]
|
6.15428e-06
|
|
|
OGG1
|
[NCBI]
|
6.15428e-06
|
|
|
CSF3R
|
[NCBI]
|
6.15428e-06
|
|
|
AHCY
|
[NCBI]
|
6.15428e-06
|
|
|
NOTCH3
|
[NCBI]
|
6.15428e-06
|
|
|
SMOH
|
[NCBI]
|
6.15428e-06
|
|
|
GRB10
|
[NCBI]
|
6.15428e-06
|
|
|
RHAG
|
[NCBI]
|
6.15428e-06
|
|
|
PRX
|
[NCBI]
|
6.15428e-06
|
|
|
YY1
|
[NCBI]
|
6.15428e-06
|
|
|
BTD
|
[NCBI]
|
6.15428e-06
|
|
|
TNFSF10
|
[NCBI]
|
6.12595e-06
|
|
|
CALCRL
|
[NCBI]
|
6.00949e-06
|
|
|
polycystic kidneys
|
[NCBI]
|
5.97907e-06
|
|
|
DCC
|
[NCBI]
|
5.87215e-06
|
|
|
GNRHR
|
[NCBI]
|
5.87215e-06
|
|
|
DFFB
|
[NCBI]
|
5.87215e-06
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
5.84997e-06
|
|
|
NRCLP1
|
[NCBI]
|
5.82142e-06
|
|
|
STL1
|
[NCBI]
|
5.82142e-06
|
|
|
MCOPS7
|
[NCBI]
|
5.82142e-06
|
|
|
TMPO
|
[NCBI]
|
5.81983e-06
|
|
|
AP3B1
|
[NCBI]
|
5.81983e-06
|
|
|
OTOF
|
[NCBI]
|
5.81983e-06
|
|
|
TNFRSF11A
|
[NCBI]
|
5.81983e-06
|
|
|
BMPR2
|
[NCBI]
|
5.81983e-06
|
|
|
MHC2TA
|
[NCBI]
|
5.81983e-06
|
|
|
SPG3A
|
[NCBI]
|
5.81983e-06
|
|
|
PPP1R12A
|
[NCBI]
|
5.81983e-06
|
|
|
EPAS1
|
[NCBI]
|
5.81983e-06
|
|
|
RAB27A
|
[NCBI]
|
5.81983e-06
|
|
|
TAP1
|
[NCBI]
|
5.81983e-06
|
|
|
PKHD1
|
[NCBI]
|
5.81983e-06
|
|
|
SLC1A3
|
[NCBI]
|
5.81983e-06
|
|
|
COCH
|
[NCBI]
|
5.81983e-06
|
|
|
FOXP2
|
[NCBI]
|
5.81983e-06
|
|
|
SDHB
|
[NCBI]
|
5.81983e-06
|
|
|
oncogene dj1
|
[NCBI]
|
5.81983e-06
|
|
|
JARID1D
|
[NCBI]
|
5.81983e-06
|
|
|
SMAX1
|
[NCBI]
|
5.78152e-06
|
|
|
NR1I2
|
[NCBI]
|
5.69978e-06
|
|
|
ABCC1
|
[NCBI]
|
5.6758e-06
|
|
|
WRN
|
[NCBI]
|
5.62309e-06
|
|
|
JARID2
|
[NCBI]
|
5.51023e-06
|
|
|
PANK2
|
[NCBI]
|
5.51023e-06
|
|
|
CDC25C
|
[NCBI]
|
5.51023e-06
|
|
|
ZEB2
|
[NCBI]
|
5.51023e-06
|
|
|
APAF1
|
[NCBI]
|
5.51023e-06
|
|
|
FLG
|
[NCBI]
|
5.51023e-06
|
|
|
TRIM25
|
[NCBI]
|
5.51023e-06
|
|
|
LRAT
|
[NCBI]
|
5.51023e-06
|
|
|
PCSK1
|
[NCBI]
|
5.51023e-06
|
|
|
LEF1
|
[NCBI]
|
5.51023e-06
|
|
|
MAPK9
|
[NCBI]
|
5.51023e-06
|
|
|
SNX1
|
[NCBI]
|
5.51023e-06
|
|
|
LAMA2
|
[NCBI]
|
5.51023e-06
|
|
|
BEST1
|
[NCBI]
|
5.51023e-06
|
|
|
CEBPA
|
[NCBI]
|
5.51023e-06
|
|
|
COL5A1
|
[NCBI]
|
5.51023e-06
|
|
|
ALOX5
|
[NCBI]
|
5.51023e-06
|
|
|
CYBA
|
[NCBI]
|
5.51023e-06
|
|
|
TERF1
|
[NCBI]
|
5.51023e-06
|
|
|
CPS1
|
[NCBI]
|
5.51023e-06
|
|
|
GABRB3
|
[NCBI]
|
5.51023e-06
|
|
|
SCN9A
|
[NCBI]
|
5.51023e-06
|
|
|
GRIN2A
|
[NCBI]
|
5.51023e-06
|
|
|
MAP2
|
[NCBI]
|
5.44738e-06
|
|
|
BCPM
|
[NCBI]
|
5.43715e-06
|
|
|
exostoses, multiple, type i
|
[NCBI]
|
5.43715e-06
|
|
|
ABCC8
|
[NCBI]
|
5.3503e-06
|
|
|
SOX2
|
[NCBI]
|
5.22254e-06
|
|
|
KCNQ1OT1
|
[NCBI]
|
5.22254e-06
|
|
|
GABRG2
|
[NCBI]
|
5.22254e-06
|
|
|
MAN2B1
|
[NCBI]
|
5.22254e-06
|
|
|
CRX
|
[NCBI]
|
5.22254e-06
|
|
|
MYO6
|
[NCBI]
|
5.22254e-06
|
|
|
PTTG1
|
[NCBI]
|
5.22254e-06
|
|
|
SLC16A2
|
[NCBI]
|
5.22254e-06
|
|
|
ANKRD1
|
[NCBI]
|
5.22254e-06
|
|
|
DLL3
|
[NCBI]
|
5.22254e-06
|
|
|
ROR2
|
[NCBI]
|
5.22254e-06
|
|
|
SCNN1A
|
[NCBI]
|
5.22254e-06
|
|
|
FGB
|
[NCBI]
|
5.22254e-06
|
|
|
ITGB3
|
[NCBI]
|
5.20044e-06
|
|
|
GIST
|
[NCBI]
|
5.14501e-06
|
|
|
EIG
|
[NCBI]
|
5.09768e-06
|
|
|
gastric cancer
|
[NCBI]
|
5.07444e-06
|
|
|
APRT
|
[NCBI]
|
5.06683e-06
|
|
|
HEMB
|
[NCBI]
|
5.01492e-06
|
|
|
HPRT1
|
[NCBI]
|
5.0026e-06
|
|
|
HLF
|
[NCBI]
|
4.95432e-06
|
|
|
ACADVL
|
[NCBI]
|
4.95432e-06
|
|
|
ITGB4
|
[NCBI]
|
4.95432e-06
|
|
|
VCAM1
|
[NCBI]
|
4.95432e-06
|
|
|
TGFBR1
|
[NCBI]
|
4.95432e-06
|
|
|
GLRA1
|
[NCBI]
|
4.95432e-06
|
|
|
HSD17B4
|
[NCBI]
|
4.95432e-06
|
|
|
SPG7
|
[NCBI]
|
4.95432e-06
|
|
|
TGM2
|
[NCBI]
|
4.95432e-06
|
|
|
JK
|
[NCBI]
|
4.95432e-06
|
|
|
TCF3
|
[NCBI]
|
4.95432e-06
|
|
|
DNTT
|
[NCBI]
|
4.95347e-06
|
|
|
EIF4E
|
[NCBI]
|
4.83426e-06
|
|
|
JAK3
|
[NCBI]
|
4.83426e-06
|
|
|
LGMD2A
|
[NCBI]
|
4.73194e-06
|
|
|
glycogen storage disease vii
|
[NCBI]
|
4.73194e-06
|
|
|
NOTCH1
|
[NCBI]
|
4.71778e-06
|
|
|
G6PT1
|
[NCBI]
|
4.70353e-06
|
|
|
PER2
|
[NCBI]
|
4.70353e-06
|
|
|
XRCC9
|
[NCBI]
|
4.70353e-06
|
|
|
IRDN
|
[NCBI]
|
4.70353e-06
|
|
|
HADHA
|
[NCBI]
|
4.70353e-06
|
|
|
GUCY2D
|
[NCBI]
|
4.70353e-06
|
|
|
TKT
|
[NCBI]
|
4.70353e-06
|
|
|
COL11A2
|
[NCBI]
|
4.70353e-06
|
|
|
FLT4
|
[NCBI]
|
4.70353e-06
|
|
|
SLC6A8
|
[NCBI]
|
4.70353e-06
|
|
|
FUT2
|
[NCBI]
|
4.70353e-06
|
|
|
KRIT1
|
[NCBI]
|
4.70353e-06
|
|
|
AHR
|
[NCBI]
|
4.49487e-06
|
|
|
tay-sachs disease, ab variant
|
[NCBI]
|
4.46841e-06
|
|
|
WNK1
|
[NCBI]
|
4.46841e-06
|
|
|
CHRNA4
|
[NCBI]
|
4.46841e-06
|
|
|
GALK1
|
[NCBI]
|
4.46841e-06
|
|
|
TMOD
|
[NCBI]
|
4.46841e-06
|
|
|
CACNA1S
|
[NCBI]
|
4.46841e-06
|
|
|
SFTPB
|
[NCBI]
|
4.46841e-06
|
|
|
C9
|
[NCBI]
|
4.46841e-06
|
|
|
NEB
|
[NCBI]
|
4.46841e-06
|
|
|
NFATC1
|
[NCBI]
|
4.46841e-06
|
|
|
EPB41
|
[NCBI]
|
4.46841e-06
|
|
|
TYMS
|
[NCBI]
|
4.44227e-06
|
|
|
von willebrand disease
|
[NCBI]
|
4.43998e-06
|
|
|
AQP2
|
[NCBI]
|
4.27761e-06
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
4.26073e-06
|
|
|
LCAT
|
[NCBI]
|
4.24976e-06
|
|
|
EIF4G1
|
[NCBI]
|
4.24747e-06
|
|
|
HR
|
[NCBI]
|
4.24747e-06
|
|
|
DSP
|
[NCBI]
|
4.24747e-06
|
|
|
TNXB
|
[NCBI]
|
4.24747e-06
|
|
|
FLT3
|
[NCBI]
|
4.24747e-06
|
|
|
WIPF1
|
[NCBI]
|
4.24747e-06
|
|
|
MAP4K2
|
[NCBI]
|
4.24747e-06
|
|
|
DRD3
|
[NCBI]
|
4.24747e-06
|
|
|
DCX
|
[NCBI]
|
4.24747e-06
|
|
|
PYGM
|
[NCBI]
|
4.24747e-06
|
|
|
TBX5
|
[NCBI]
|
4.24747e-06
|
|
|
CDPX2
|
[NCBI]
|
4.10278e-06
|
|
|
XLP1
|
[NCBI]
|
4.10278e-06
|
|
|
mitochondrial complex i deficiency
|
[NCBI]
|
4.10278e-06
|
|
|
walker-warburg syndrome
|
[NCBI]
|
4.10278e-06
|
|
|
DRD4
|
[NCBI]
|
4.07198e-06
|
|
|
RET
|
[NCBI]
|
4.07092e-06
|
|
|
PAX5
|
[NCBI]
|
4.03943e-06
|
|
|
GHSR
|
[NCBI]
|
4.03943e-06
|
|
|
ERCC1
|
[NCBI]
|
4.03943e-06
|
|
|
PDGFRA
|
[NCBI]
|
4.03943e-06
|
|
|
HOXD13
|
[NCBI]
|
4.03943e-06
|
|
|
MPL
|
[NCBI]
|
4.03943e-06
|
|
|
PLOD1
|
[NCBI]
|
4.03943e-06
|
|
|
SLC5A5
|
[NCBI]
|
4.03943e-06
|
|
|
PLSCR1
|
[NCBI]
|
4.03943e-06
|
|
|
EBF
|
[NCBI]
|
4.03943e-06
|
|
|
ADAMTS13
|
[NCBI]
|
4.03943e-06
|
|
|
AMPD1
|
[NCBI]
|
4.03943e-06
|
|
|
GATA4
|
[NCBI]
|
4.03943e-06
|
|
|
MC2R
|
[NCBI]
|
4.03943e-06
|
|
|
ARNTL
|
[NCBI]
|
4.03943e-06
|
|
|
FUS
|
[NCBI]
|
4.03943e-06
|
|
|
ATP2A2
|
[NCBI]
|
4.03943e-06
|
|
|
FGFR1
|
[NCBI]
|
4.00018e-06
|
|
|
AKR1B1
|
[NCBI]
|
3.99178e-06
|
|
|
VCP
|
[NCBI]
|
3.97254e-06
|
|
|
HBA1
|
[NCBI]
|
3.87981e-06
|
|
|
APS1
|
[NCBI]
|
3.85233e-06
|
|
|
PLAT
|
[NCBI]
|
3.84316e-06
|
|
|
AACT
|
[NCBI]
|
3.84316e-06
|
|
|
HSPA1A
|
[NCBI]
|
3.84316e-06
|
|
|
LCK
|
[NCBI]
|
3.84316e-06
|
|
|
WFS1
|
[NCBI]
|
3.84316e-06
|
|
|
CLTC
|
[NCBI]
|
3.84316e-06
|
|
|
LAMB3
|
[NCBI]
|
3.84316e-06
|
|
|
CASP8
|
[NCBI]
|
3.84316e-06
|
|
|
NKX2-1
|
[NCBI]
|
3.84316e-06
|
|
|
LTC4S
|
[NCBI]
|
3.84316e-06
|
|
|
CMTX1
|
[NCBI]
|
3.81398e-06
|
|
|
SMA3
|
[NCBI]
|
3.81398e-06
|
|
|
GCPS
|
[NCBI]
|
3.81398e-06
|
|
|
MDLS
|
[NCBI]
|
3.81398e-06
|
|
|
ADA
|
[NCBI]
|
3.78428e-06
|
|
|
XIST
|
[NCBI]
|
3.68705e-06
|
|
|
fabry disease
|
[NCBI]
|
3.68318e-06
|
|
|
UROS
|
[NCBI]
|
3.65767e-06
|
|
|
IRF1
|
[NCBI]
|
3.65767e-06
|
|
|
CDH23
|
[NCBI]
|
3.65767e-06
|
|
|
TRAF6
|
[NCBI]
|
3.65767e-06
|
|
|
PINK1
|
[NCBI]
|
3.65767e-06
|
|
|
CASP1
|
[NCBI]
|
3.65767e-06
|
|
|
HBG1
|
[NCBI]
|
3.59598e-06
|
|
|
LAM
|
[NCBI]
|
3.57592e-06
|
|
|
OCA1A
|
[NCBI]
|
3.54109e-06
|
|
|
ATS
|
[NCBI]
|
3.54109e-06
|
|
|
RHO
|
[NCBI]
|
3.53181e-06
|
|
|
RPS19
|
[NCBI]
|
3.48211e-06
|
|
|
SRD5A2
|
[NCBI]
|
3.48211e-06
|
|
|
FGFR4
|
[NCBI]
|
3.48211e-06
|
|
|
MYH9
|
[NCBI]
|
3.48211e-06
|
|
|
SLC3A1
|
[NCBI]
|
3.48211e-06
|
|
|
TBP
|
[NCBI]
|
3.46858e-06
|
|
|
MTTL1
|
[NCBI]
|
3.41964e-06
|
|
|
AIS
|
[NCBI]
|
3.38187e-06
|
|
|
CHS
|
[NCBI]
|
3.38187e-06
|
|
|
CD59
|
[NCBI]
|
3.31571e-06
|
|
|
MTND2
|
[NCBI]
|
3.31571e-06
|
|
|
GLO1
|
[NCBI]
|
3.31571e-06
|
|
|
SCN1A
|
[NCBI]
|
3.31571e-06
|
|
|
SP7
|
[NCBI]
|
3.31571e-06
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
3.28326e-06
|
|
|
PDS
|
[NCBI]
|
3.28326e-06
|
|
|
mucolipidosis ii
|
[NCBI]
|
3.28326e-06
|
|
|
TRPV1
|
[NCBI]
|
3.25075e-06
|
|
|
TLR2
|
[NCBI]
|
3.16063e-06
|
|
|
CHM
|
[NCBI]
|
3.15779e-06
|
|
|
GJA5
|
[NCBI]
|
3.15779e-06
|
|
|
HDAC4
|
[NCBI]
|
3.15779e-06
|
|
|
CTSK
|
[NCBI]
|
3.15779e-06
|
|
|
NOS1
|
[NCBI]
|
3.15779e-06
|
|
|
TSG101
|
[NCBI]
|
3.15779e-06
|
|
|
GSTM1
|
[NCBI]
|
3.15779e-06
|
|
|
CD4
|
[NCBI]
|
3.15779e-06
|
|
|
PTPN1
|
[NCBI]
|
3.15779e-06
|
|
|
PPID
|
[NCBI]
|
3.15779e-06
|
|
|
MVK
|
[NCBI]
|
3.15779e-06
|
|
|
HHF1
|
[NCBI]
|
3.03968e-06
|
|
|
ITGA2B
|
[NCBI]
|
3.00775e-06
|
|
|
PROP1
|
[NCBI]
|
3.00775e-06
|
|
|
krabbe disease
|
[NCBI]
|
2.91117e-06
|
|
|
IKBKB
|
[NCBI]
|
2.86503e-06
|
|
|
IPF1
|
[NCBI]
|
2.86503e-06
|
|
|
PITX2
|
[NCBI]
|
2.86503e-06
|
|
|
C1NH
|
[NCBI]
|
2.86503e-06
|
|
|
TAF1
|
[NCBI]
|
2.86503e-06
|
|
|
COL17A1
|
[NCBI]
|
2.86503e-06
|
|
|
ARX
|
[NCBI]
|
2.86503e-06
|
|
|
APEX
|
[NCBI]
|
2.86503e-06
|
|
|
TTN
|
[NCBI]
|
2.72916e-06
|
|
|
GSTP1
|
[NCBI]
|
2.72916e-06
|
|
|
DISC1
|
[NCBI]
|
2.72916e-06
|
|
|
ALDH1A2
|
[NCBI]
|
2.72916e-06
|
|
|
NCOA2
|
[NCBI]
|
2.72916e-06
|
|
|
CAV1
|
[NCBI]
|
2.72916e-06
|
|
|
PTX3
|
[NCBI]
|
2.72916e-06
|
|
|
phenylketonuria
|
[NCBI]
|
2.66018e-06
|
|
|
TNFSF6
|
[NCBI]
|
2.62564e-06
|
|
|
NR1H4
|
[NCBI]
|
2.59969e-06
|
|
|
ACVRL1
|
[NCBI]
|
2.59969e-06
|
|
|
NPC1
|
[NCBI]
|
2.59969e-06
|
|
|
SLBP
|
[NCBI]
|
2.59969e-06
|
|
|
ATXN1
|
[NCBI]
|
2.59969e-06
|
|
|
KCNJ11
|
[NCBI]
|
2.59969e-06
|
|
|
CYP11B2
|
[NCBI]
|
2.59969e-06
|
|
|
DST
|
[NCBI]
|
2.59969e-06
|
|
|
EDN3
|
[NCBI]
|
2.59969e-06
|
|
|
CAV3
|
[NCBI]
|
2.59969e-06
|
|
|
CF
|
[NCBI]
|
2.52808e-06
|
|
|
FAAH
|
[NCBI]
|
2.52103e-06
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
2.47623e-06
|
|
|
PTPN11
|
[NCBI]
|
2.47623e-06
|
|
|
CDKN1B
|
[NCBI]
|
2.47623e-06
|
|
|
ALPL
|
[NCBI]
|
2.47623e-06
|
|
|
CRY1
|
[NCBI]
|
2.47623e-06
|
|
|
GCH1
|
[NCBI]
|
2.47623e-06
|
|
|
HSAN3
|
[NCBI]
|
2.38745e-06
|
|
|
KRT5
|
[NCBI]
|
2.35839e-06
|
|
|
BANF1
|
[NCBI]
|
2.35839e-06
|
|
|
PML
|
[NCBI]
|
2.35839e-06
|
|
|
MAOB
|
[NCBI]
|
2.35839e-06
|
|
|
TERC
|
[NCBI]
|
2.35839e-06
|
|
|
HGS
|
[NCBI]
|
2.35839e-06
|
|
|
DYSF
|
[NCBI]
|
2.35839e-06
|
|
|
RECQL3
|
[NCBI]
|
2.35839e-06
|
|
|
MTND5
|
[NCBI]
|
2.35839e-06
|
|
|
EV
|
[NCBI]
|
2.35299e-06
|
|
|
SLC6A4
|
[NCBI]
|
2.31685e-06
|
|
|
MPZ
|
[NCBI]
|
2.31179e-06
|
|
|
ACADM
|
[NCBI]
|
2.28023e-06
|
|
|
homocystinuria
|
[NCBI]
|
2.24967e-06
|
|
|
CFI
|
[NCBI]
|
2.24587e-06
|
|
|
PAFAH1B1
|
[NCBI]
|
2.24587e-06
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
2.19411e-06
|
|
|
VMD
|
[NCBI]
|
2.19411e-06
|
|
|
GLB1
|
[NCBI]
|
2.13834e-06
|
|
|
ACCN2
|
[NCBI]
|
2.13834e-06
|
|
|
FMO3
|
[NCBI]
|
2.13834e-06
|
|
|
CBD
|
[NCBI]
|
2.13834e-06
|
|
|
SPG4
|
[NCBI]
|
2.13834e-06
|
|
|
CPE
|
[NCBI]
|
2.12926e-06
|
|
|
GDF5
|
[NCBI]
|
2.03554e-06
|
|
|
STAT5B
|
[NCBI]
|
2.03554e-06
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
2.03554e-06
|
|
|
PHEX
|
[NCBI]
|
1.93721e-06
|
|
|
MDM2
|
[NCBI]
|
1.93721e-06
|
|
|
PAI1
|
[NCBI]
|
1.93721e-06
|
|
|
CDO
|
[NCBI]
|
1.93721e-06
|
|
|
GATA1
|
[NCBI]
|
1.93721e-06
|
|
|
PRLR
|
[NCBI]
|
1.90312e-06
|
|
|
STAR
|
[NCBI]
|
1.90283e-06
|
|
|
LMNA
|
[NCBI]
|
1.8495e-06
|
|
|
ACADS
|
[NCBI]
|
1.84311e-06
|
|
|
FOXO1A
|
[NCBI]
|
1.84311e-06
|
|
|
glycogen storage disease i
|
[NCBI]
|
1.84311e-06
|
|
|
MTCO1
|
[NCBI]
|
1.84311e-06
|
|
|
CYP3A4
|
[NCBI]
|
1.84311e-06
|
|
|
BAX
|
[NCBI]
|
1.84311e-06
|
|
|
SLC26A4
|
[NCBI]
|
1.84311e-06
|
|
|
SCIDX1
|
[NCBI]
|
1.84023e-06
|
|
|
HFE
|
[NCBI]
|
1.83017e-06
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
1.80036e-06
|
|
|
IHH
|
[NCBI]
|
1.79896e-06
|
|
|
FRDA
|
[NCBI]
|
1.76759e-06
|
|
|
GRIA2
|
[NCBI]
|
1.75303e-06
|
|
|
RS1
|
[NCBI]
|
1.75303e-06
|
|
|
MICA
|
[NCBI]
|
1.75303e-06
|
|
|
RUNX2
|
[NCBI]
|
1.75303e-06
|
|
|
PPT1
|
[NCBI]
|
1.66676e-06
|
|
|
NR0B1
|
[NCBI]
|
1.66676e-06
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
1.66676e-06
|
|
|
GPI
|
[NCBI]
|
1.62839e-06
|
|
|
MC1R
|
[NCBI]
|
1.59783e-06
|
|
|
TNFRSF1B
|
[NCBI]
|
1.58412e-06
|
|
|
CUTL1
|
[NCBI]
|
1.58412e-06
|
|
|
LIF
|
[NCBI]
|
1.58412e-06
|
|
|
EDN1
|
[NCBI]
|
1.58412e-06
|
|
|
FY
|
[NCBI]
|
1.58412e-06
|
|
|
fucosidosis
|
[NCBI]
|
1.58412e-06
|
|
|
VDR
|
[NCBI]
|
1.51982e-06
|
|
|
HBB
|
[NCBI]
|
1.51822e-06
|
|
|
MST1
|
[NCBI]
|
1.50494e-06
|
|
|
FXYD1
|
[NCBI]
|
1.50494e-06
|
|
|
SLC16A1
|
[NCBI]
|
1.50494e-06
|
|
|
SRC
|
[NCBI]
|
1.50444e-06
|
|
|
APP
|
[NCBI]
|
1.4963e-06
|
|
|
DNMT1
|
[NCBI]
|
1.4963e-06
|
|
|
TS
|
[NCBI]
|
1.46107e-06
|
|
|
CDK5
|
[NCBI]
|
1.44777e-06
|
|
|
MMP3
|
[NCBI]
|
1.42905e-06
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
1.42905e-06
|
|
|
HD
|
[NCBI]
|
1.39054e-06
|
|
|
PGR
|
[NCBI]
|
1.39042e-06
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
1.38433e-06
|
|
|
BRRS
|
[NCBI]
|
1.38433e-06
|
|
|
MAPK1
|
[NCBI]
|
1.3717e-06
|
|
|
DSTN
|
[NCBI]
|
1.35631e-06
|
|
|
SOCS1
|
[NCBI]
|
1.35631e-06
|
|
|
GRIA1
|
[NCBI]
|
1.35631e-06
|
|
|
MTCYB
|
[NCBI]
|
1.35631e-06
|
|
|
CYP17A1
|
[NCBI]
|
1.28657e-06
|
|
|
USF1
|
[NCBI]
|
1.28657e-06
|
|
|
DHFR
|
[NCBI]
|
1.27079e-06
|
|
|
OPMD
|
[NCBI]
|
1.24849e-06
|
|
|
ADHD
|
[NCBI]
|
1.24849e-06
|
|
|
HDC
|
[NCBI]
|
1.23441e-06
|
|
|
DAZ
|
[NCBI]
|
1.21971e-06
|
|
|
GSR
|
[NCBI]
|
1.21971e-06
|
|
|
TCRA
|
[NCBI]
|
1.21971e-06
|
|
|
PNMT
|
[NCBI]
|
1.17677e-06
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
1.1556e-06
|
|
|
MTATP6
|
[NCBI]
|
1.1556e-06
|
|
|
AMH
|
[NCBI]
|
1.13559e-06
|
|
|
PAM
|
[NCBI]
|
1.13095e-06
|
|
|
RNASE2
|
[NCBI]
|
1.13095e-06
|
|
|
MHS1
|
[NCBI]
|
1.12552e-06
|
|
|
OCP
|
[NCBI]
|
1.12552e-06
|
|
|
PLTP
|
[NCBI]
|
1.10418e-06
|
|
|
factor x deficiency
|
[NCBI]
|
1.09413e-06
|
|
|
DCT
|
[NCBI]
|
1.09413e-06
|
|
|
PRKCM
|
[NCBI]
|
1.09386e-06
|
|
|
CASR
|
[NCBI]
|
1.02547e-06
|
|
|
EPOR
|
[NCBI]
|
1.02361e-06
|
|
|
CFH
|
[NCBI]
|
1.02213e-06
|
|
|
CLS
|
[NCBI]
|
1.00856e-06
|
|
|
STAT3
|
[NCBI]
|
9.91787e-07
|
|
|
GJB1
|
[NCBI]
|
9.87475e-07
|
|
|
AKT1
|
[NCBI]
|
9.78681e-07
|
|
|
NTRK1
|
[NCBI]
|
9.78681e-07
|
|
|
PRF1
|
[NCBI]
|
9.78681e-07
|
|
|
OSM
|
[NCBI]
|
9.53499e-07
|
|
|
SOD1
|
[NCBI]
|
9.52423e-07
|
|
|
NP
|
[NCBI]
|
9.24504e-07
|
|
|
CACNA1A
|
[NCBI]
|
9.24504e-07
|
|
|
RP2
|
[NCBI]
|
9.24504e-07
|
|
|
ARPKD
|
[NCBI]
|
8.99455e-07
|
|
|
DSG3
|
[NCBI]
|
8.72571e-07
|
|
|
EGFR
|
[NCBI]
|
8.49472e-07
|
|
|
CDLS1
|
[NCBI]
|
8.04014e-07
|
|
|
ED1
|
[NCBI]
|
7.97914e-07
|
|
|
MITF
|
[NCBI]
|
7.95627e-07
|
|
|
PTHLH
|
[NCBI]
|
7.81653e-07
|
|
|
FLNA
|
[NCBI]
|
7.75103e-07
|
|
|
AGT
|
[NCBI]
|
7.75103e-07
|
|
|
APOB
|
[NCBI]
|
7.32266e-07
|
|
|
ABL1
|
[NCBI]
|
7.29412e-07
|
|
|
BBS
|
[NCBI]
|
7.25803e-07
|
|
|
AGER
|
[NCBI]
|
7.08881e-07
|
|
|
KIT
|
[NCBI]
|
6.85654e-07
|
|
|
A2M
|
[NCBI]
|
6.4376e-07
|
|
|
PLP1
|
[NCBI]
|
6.4376e-07
|
|
|
DBI
|
[NCBI]
|
6.4195e-07
|
|
|
SOD2
|
[NCBI]
|
6.3967e-07
|
|
|
bare lymphocyte syndrome, type ii
|
[NCBI]
|
6.16387e-07
|
|
|
NPC1
|
[NCBI]
|
6.16387e-07
|
|
|
DRD2
|
[NCBI]
|
6.03666e-07
|
|
|
REN
|
[NCBI]
|
6.03666e-07
|
|
|
PSEN2
|
[NCBI]
|
6.03666e-07
|
|
|
MAP3K5
|
[NCBI]
|
5.77517e-07
|
|
|
CEL
|
[NCBI]
|
5.65312e-07
|
|
|
ZS
|
[NCBI]
|
5.54007e-07
|
|
|
HBD
|
[NCBI]
|
5.28638e-07
|
|
|
TPO
|
[NCBI]
|
5.24868e-07
|
|
|
JAK2
|
[NCBI]
|
5.13094e-07
|
|
|
CDH1
|
[NCBI]
|
4.93591e-07
|
|
|
PGK1
|
[NCBI]
|
4.93591e-07
|
|
|
ATF3
|
[NCBI]
|
4.93591e-07
|
|
|
LQT1
|
[NCBI]
|
4.61877e-07
|
|
|
ARMD1
|
[NCBI]
|
4.61877e-07
|
|
|
WT1
|
[NCBI]
|
4.60116e-07
|
|
|
HNF4A
|
[NCBI]
|
4.60116e-07
|
|
|
TNC
|
[NCBI]
|
4.56572e-07
|
|
|
BCR
|
[NCBI]
|
4.40917e-07
|
|
|
CBX5
|
[NCBI]
|
4.04106e-07
|
|
|
MMP2
|
[NCBI]
|
3.97692e-07
|
|
|
LCN2
|
[NCBI]
|
3.97692e-07
|
|
|
IRS1
|
[NCBI]
|
3.68648e-07
|
|
|
BTC
|
[NCBI]
|
3.68648e-07
|
|
|
PLG
|
[NCBI]
|
3.53237e-07
|
|
|
RB1
|
[NCBI]
|
3.45428e-07
|
|
|
SPARC
|
[NCBI]
|
3.40991e-07
|
|
|
PTK2
|
[NCBI]
|
3.21894e-07
|
|
|
LIPC
|
[NCBI]
|
3.1468e-07
|
|
|
TGFB1
|
[NCBI]
|
3.1468e-07
|
|
|
GCCR
|
[NCBI]
|
2.89676e-07
|
|
|
NR5A1
|
[NCBI]
|
2.65939e-07
|
|
|
CTNNB1
|
[NCBI]
|
2.65939e-07
|
|
|
THPO
|
[NCBI]
|
2.43435e-07
|
|
|
REG3A
|
[NCBI]
|
2.43435e-07
|
|
|
SHH
|
[NCBI]
|
2.27079e-07
|
|
|
MAPK3
|
[NCBI]
|
2.22129e-07
|
|
|
ANG
|
[NCBI]
|
2.22129e-07
|
|
|
TPMT
|
[NCBI]
|
2.20355e-07
|
|
|
NPM1
|
[NCBI]
|
2.0622e-07
|
|
|
PPIA
|
[NCBI]
|
2.0622e-07
|
|
|
TLR3
|
[NCBI]
|
2.01986e-07
|
|
|
gaucher disease, type i
|
[NCBI]
|
1.81929e-07
|
|
|
BMP4
|
[NCBI]
|
1.79148e-07
|
|
|
TLR9
|
[NCBI]
|
1.79148e-07
|
|
|
LRP1
|
[NCBI]
|
1.75481e-07
|
|
|
PLK1
|
[NCBI]
|
1.70075e-07
|
|
|
PPARG
|
[NCBI]
|
1.66224e-07
|
|
|
NR0B2
|
[NCBI]
|
1.65068e-07
|
|
|
FSHR
|
[NCBI]
|
1.65068e-07
|
|
|
LOX
|
[NCBI]
|
1.65068e-07
|
|
|
TERT
|
[NCBI]
|
1.58427e-07
|
|
|
ILK
|
[NCBI]
|
1.56978e-07
|
|
|
COL1A1
|
[NCBI]
|
1.53716e-07
|
|
|
MEN2A
|
[NCBI]
|
1.4258e-07
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
1.4258e-07
|
|
|
ARSA
|
[NCBI]
|
1.3244e-07
|
|
|
PLAUR
|
[NCBI]
|
1.29981e-07
|
|
|
LS
|
[NCBI]
|
1.17371e-07
|
|
|
LPI
|
[NCBI]
|
1.08364e-07
|
|
|
MAOA
|
[NCBI]
|
1.08e-07
|
|
|
RYR1
|
[NCBI]
|
1.0388e-07
|
|
|
PCI
|
[NCBI]
|
9.76863e-08
|
|
|
BMP2
|
[NCBI]
|
9.10622e-08
|
|
|
UGB
|
[NCBI]
|
9.10622e-08
|
|
|
PC
|
[NCBI]
|
8.78351e-08
|
|
|
PSEN1
|
[NCBI]
|
8.13174e-08
|
|
|
SLC11A2
|
[NCBI]
|
7.91856e-08
|
|
|
NS1
|
[NCBI]
|
6.66987e-08
|
|
|
RP
|
[NCBI]
|
6.45434e-08
|
|
|
MTR
|
[NCBI]
|
5.81654e-08
|
|
|
HRG
|
[NCBI]
|
5.81654e-08
|
|
|
CMT1A
|
[NCBI]
|
5.47011e-08
|
|
|
CPB2
|
[NCBI]
|
5.32199e-08
|
|
|
factor v deficiency
|
[NCBI]
|
4.89778e-08
|
|
|
BSG
|
[NCBI]
|
4.89778e-08
|
|
|
GUSB
|
[NCBI]
|
4.58076e-08
|
|
|
DCK
|
[NCBI]
|
3.79548e-08
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
3.49543e-08
|
|
|
VIM
|
[NCBI]
|
3.2538e-08
|
|
|
SCD
|
[NCBI]
|
2.67004e-08
|
|
|
IDE
|
[NCBI]
|
2.67004e-08
|
|
|
CLU
|
[NCBI]
|
2.64572e-08
|
|
|
ZFP36
|
[NCBI]
|
2.05665e-08
|
|
|
PLN
|
[NCBI]
|
2.05665e-08
|
|
|
asthma, susceptibility to
|
[NCBI]
|
1.97428e-08
|
|
|
hypertension, essential
|
[NCBI]
|
1.97428e-08
|
|
|
ALS1
|
[NCBI]
|
1.97428e-08
|
|
|
PDCD8
|
[NCBI]
|
1.93596e-08
|
|
|
IL4
|
[NCBI]
|
1.66712e-08
|
|
|
CDK2
|
[NCBI]
|
1.64744e-08
|
|
|
LCT
|
[NCBI]
|
1.54532e-08
|
|
|
FPGS
|
[NCBI]
|
5.90556e-09
|
|
|
CDK4
|
[NCBI]
|
3.21845e-09
|
|
|
HEXA
|
[NCBI]
|
2.43314e-09
|
|
|
TNFRSF1A
|
[NCBI]
|
2.43314e-09
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
2.02959e-09
|
|
|
SDS
|
[NCBI]
|
1.66742e-09
|
|
|
GCK
|
[NCBI]
|
3.02575e-11
|
|